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ABSTRACT 
There are a number of studies that investigate the association between endotoxin and 
respiratory outcomes, but few examine ambient endotoxin particularly in smaller industrial cities 
in Canada.  In epidemiological studies of respiratory diseases, environmental factors are of major 
concern to health.  The aims of this study are: (1) to assess ambient endotoxin levels in two 
communities in southern Saskatchewan (SK), Canada; and (2) to examine the association between 
ambient endotoxin levels and forced expiratory volume in one second (FEV1) among older adult 
residents of the two communities.  This work is part of the larger Air Quality and Lung Health 
Study conducted in the cities of Estevan and Swift Current, SK.  Ambient environmental and 
personal respiratory health measures were collected in three periods (phases) of three month 
durations.   
To assess ambient endotoxin levels in the two communities, samples were collected in spring 
2013 (Phase 1), fall 2013 (Phase 2), and spring 2014 (Phase 3).  The phase sampling strategy was 
employed to account for potential seasonal variations in endotoxin.  Consecutive full-week (7 day 
accumulation) particle mass size fractions (PM2.5 and PM10) were gravimetrically collected for 
each of the communities for the 3-month duration of each phase (1-3) and analyzed for endotoxin 
load (EU/µg) and endotoxin concentration (EU/m3).  Geometric means were calculated for 
endotoxin load and concentration for each particle size fraction (PM2.5 and PM10), each 
community, and each phase.  Differences were tested between particle size fractions, and between 
communities.   
The highest levels of endotoxin (EU/µg) found in Estevan were 0.02 (Phase 1), 0.03 (Phase 
2) and 0.01(Phase 3), while endotoxin (EU/m3) were 0.04 (Phase 1), 0.07 (Phase 2) and 0.02 (Phase 
3). Similar trends were found in Swift Current with 0.04 (Phase 1), 0.10 (Phase 2), and 0.05 (Phase 
3) in endotoxin (EU/µg), while 0.07 (Phase 1), 0.13 (Phase 2), and 0.08 (Phase 3) were found in 
endotoxin (EU/m3).  Estevan had no significant differences in endotoxin load (EU/µg) between 
size fractions for any of the phases.  However, endotoxin load was significantly higher in the PM2.5 
size fraction as compared to the PM10 for both Phases 2 and 3 for Swift Current.  For both 
communities, in all phases, there was significantly greater endotoxin concentration (EU/m3) in 
PM2.5 as compared to PM10.   
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Comparing communities, Swift Current had significantly greater endotoxin load (EU/µg) in 
the PM2.5 size fraction (in all phases) and the PM10 size fractions in Phases 2 and 3 as compared to 
Estevan.  Similar trends were observed for endotoxin concentration (EU/m3) in PM2.5 where mean 
concentrations were greater in Swift Current as compared to Estevan for all phases, but the 
difference between communities was significant only in Phase 3 (p<0.0001).  For PM10 only in 
Phase 3 were endotoxin concentrations significantly different between communities with Swift 
Current having higher mean levels (p<0.02). 
Endotoxin load and concentration were evaluated against pulmonary function measures 
(FEV1) in older adults in the two communities to test the association between ambient endotoxin 
levels and forced expiratory volume in one second (FEV1) among older adult residents of the two 
communities.  Twice daily (morning and evening) FEV1 were collected from older adults (>50 
years) from both communities over the duration of each of the three phases.  Weekly (7 days) 
morning and evening mean, minimum and maximum FEV1 were calculated to match endotoxin 
collection/analysis periods.  
Despite the relatively low levels of endotoxin in these communities, personal respiratory 
health measures revealed that there were significant associations in Swift Current Phase 3 
measures between mean and max FEV1 and PM2.5 endotoxin load and concentration, and these 
were the highest levels that were measured for either community or any phase. 
 Taken together these results indicate that endotoxin levels in ambient measures of 
particulate vary by size fraction with higher concentrations attributed to the smaller size fraction 
(PM2.5).  Endotoxin in ambient air particulate has the potential to influence respiratory outcomes.  
Even at what is considered low levels a continuous exposure to endotoxin can be associated with 
respiratory health effects as was seen in Swift Current during Phase 3. 
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CHAPTER 1 INTRODUCTION 
1.1 Overview 
Particulate pollution is comprised of small and large liquid and solid particles released from 
natural and human sources.  Natural sources include dust, soil particulate, pollens, products of 
forest fires, and volcanic ash while human sources include fuel combustion from vehicles, power 
plant emissions, industrial processes, mining activities, cigarette smoking and wood stove burning 
[1].  The quantity, quality, and size of particulate matter (PM) in the ambient environment is 
influenced by the number and type of sources.  PM2.5 (fine inhalable particulate matter with a mean 
aerodynamic diameter of 2.5 µm or less) and PM10 (inhalable particulate matter with mean 
aerodynamic diameter less than 10 µm) are important components of particulate pollution [1, 2] 
that have been associated with respiratory health outcomes [1, 3].  Less is known about the impact 
of microbial exposure, present in ambient particulate matter in different background environments, 
on respiratory health outcomes.  Bacterial endotoxin represents such a microbial exposure. 
Endotoxin, a molecule released into the air from the outer membrane of gram-negative 
bacteria [4], has been identified as an important biological component of particulate matter [5]. 
Endotoxin is a common component in organic dusts [5] such as agricultural environments, textile 
facilities, and waste processing areas [6, 7].  For instance, intensive animal facilities increase the 
levels of endotoxin in rural areas compared to urban areas [8, 9].  Studies suggest that endotoxin 
adsorbed in particulate matter is able to elicit respiratory health effects [10].  Inhalation of 
particulate matter embedded with endotoxin at different quantity and from various sources has 
been linked to respiratory outcomes including nose and throat irritation, chest tightness, cough, 
shortness of breath, acute airway flow restriction and inflammation in the lung [10].  However, 
respiratory health impairments with respect to endotoxin exposure from the ambient environment 
has not been widely studied although it has been well substantiated in occupational environmental 
studies [11].  Studies have revealed that endotoxin is an important microbial component in ambient 
particulate matter and an important modifier of toxicity [12, 13].  For instance, a study discovered 
that 20% of ambient airborne particulate matter might contain biological components and 
endotoxin concentration might reach levels as high as 30 EU/mg [9, 14]. 
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The depth of penetration and response to endotoxin by the human respiratory system is 
strongly influenced by the size of particulate matter to which endotoxin is attached [1].  Studies 
suggest that the contribution of endotoxin to particulate matter toxicity depends on the size of 
inhaled particulate containing endotoxin [10].  Measuring the distribution of endotoxin in the 
particulate fractions of aerosols is therefore important in associations with respiratory health 
effects.  
One of the fundamental measures of respiratory health is spirometry.  Spirometry provides 
objective and highly reproducible measures of airflow limitation.  The spirometry parameter, 
forced expiratory volume in 1 second (FEV1) is a widely used assessment method in lung health 
studies to assess pulmonary function [15]. 
1.2 Rationale of the study 
In 2004, a study in two rural communities in Saskatchewan found a higher prevalence of 
asthma in children in Estevan as compared to Swift Current [16].  The prevalence of ever asthma 
in Estevan was 21.4% compared to 16.2% in Swift Current.  Furthermore, a higher proportion of 
girls (19.7%) in Estevan reported a history of asthma when compared to girls in Swift Current 
(12.5%) [16].  In addition to other factors, there are different primary industries in these two 
communities with Swift Current primarily involved in agricultural operations and Estevan with 
agricultural activities and industrial activities including coal mining operations and coal energy 
generation.  These industries might contribute to the particulate air pollution, of which endotoxin 
can be associated, and potentially the respiratory health outcomes of residents [17].  There is 
limited knowledge on the composition of particulate matter in Saskatchewan especially with 
regard to the levels of endotoxin in the size fractions of ambient particulate matter and associations 
with respiratory outcomes. 
Indoor and occupational endotoxin levels have been evaluated in various studies. However 
knowledge of the ambient composition of endotoxin is limited, particularly for small urban centers 
such as those common in Saskatchewan.  Given differences in the prevalence of asthma rates in 
Estevan and Swift Current [16], and differences in pollution sources, we sought to evaluate the 
level of endotoxin and its association with respiratory outcomes in these communities.  Therefore, 
this study focused on the assessment of ambient endotoxin distribution measured in inhalable 
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particulate fractions (PM2.5 and PM10).  Furthermore, the study assessed the associations between 
endotoxin levels in PM2.5 and PM10 and FEV1 as a respiratory health outcome measure. 
1.3 Thesis organization 
The approach used in this thesis was manuscript-style.  This thesis was based around two 
separate, but related, manuscripts.  The literature review addressed the knowledge around the field 
of study including the current knowledge around ambient particulate exposure, its composition 
and methods of assessment, and its relationship with respiratory health. Next, the overall 
methodology of the study was described.  This was followed by two chapters, one for each paper 
in the thesis.  
The first manuscript “Assessment of endotoxin content in PM2.5 and PM10 particle mass of 
ambient aerosols in two Saskatchewan communities” described the levels of ambient endotoxin in 
PM2.5 and PM10 collected from different phases of study in Estevan and Swift Current 
communities.  This manuscript also compares: 1) ambient endotoxin levels found in PM2.5 and 
PM10 in each community and within each phase of the study; 2) ambient endotoxin levels found in 
PM2.5 from Estevan and PM2.5 from Swift Current, and likewise for PM10, in each phase of the 
study. 
The endotoxin levels from the first manuscript were used to investigate possible associations 
with the respiratory health outcome of Forced Expiratory Volume in 1 second (FEV1) from a 
human study population in the second manuscript.  The second manuscript “Association between 
ambient endotoxin and lung function among the adult residents in two Saskatchewan 
communities” furthered the significance of the findings in the first manuscript by examining the 
associations between the ambient endotoxin levels in the different particulate size fractions and 
lung function in terms of FEV1 measured in the morning and evening from both Estevan and Swift 
Current communities, separately. 
Finally, the thesis ends with the discussion chapter which brings together the two papers and 
how they fit into the current literature, discusses overall considerations of the study quality, 
limitations, and strengths, and ends with recommendations for future work. 
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CHAPTER 2 LITERATURE REVIEW 
2.1 Scope of literature review 
The purpose of this study was to assess the levels of ambient endotoxin by particle size 
fraction as well as associations between endotoxin levels and forced expiratory volume in 1 second 
(FEV1) in two small urban communities in Saskatchewan.  The thesis literature review aims to 
explore the knowledge, and previous research works about ambient endotoxin and ambient 
endotoxin effects on FEV1.  The review is organized into three sections to address the study 
purpose.  The first section considers the entity of particulate pollution as an element of air pollution 
including endotoxin.  This section aims to better understand endotoxin as a biological component 
in particulate pollution.  The second section describes the respiratory health related to ambient air 
pollution and how it is assessed.  The final section defines the current knowledge regarding 
ambient endotoxin and lung function. 
2.2 Methods of the review 
The literature search was completed using search engines such as PubMed, Google 
Scholar, the University of Saskatchewan’s Library literature and hardcopy journals in the library 
for current scientific research studies.  Some articles were identified through the reference 
sections of relevant articles.  The search words included ‘endotoxin’, ‘exposure’, ‘airborne’, 
‘lung function’, ‘respiratory illnesses’, ‘respiratory diseases’, ‘particulate matter’ ‘ambient 
pollutant’, ‘spirometry’ ‘force expiratory volume in 1 second (FEV1)’ and the combination of 
these words.  Studies that used animals for the experiment and those not written in English 
Language were excluded from the review. 
2.3 Ambient particulate air pollution and the role of endotoxin 
2.3.1 Air pollution 
Air pollution is a complex entity that varies in space and time and contains hundreds of 
compounds [1].  It has been widely recognized as a threat to human respiratory health [2]. Ambient 
air contains vapours and particulate matter with contaminants classified as human generated, 
natural, or secondary (from chemical reactions in the air) [3].  Particulate air pollution occurs when 
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substances, including particulates and biological molecules, are released or introduced into the 
atmosphere [4]. 
2.3.1.1 Major constituents of air pollution 
The quality of air can be polluted due to the presence of one or more pollutants considered 
as main pollutants, including ground level ozone [O3], sulphur oxides [SOx], nitrogen oxides 
[NOx], and particulates [5].  The levels of the pollutants in the air vary and are influenced by 
several factors ranging from proximity to emission sources, weather condition, chemical reaction 
in the air and the transport over long distances by winds [5].  Pollutant measurements are 
influenced by wind speed and direction, temperature, relative humidity and air pressure [6]. 
Ozone is formed in the lower atmosphere when precursor gases such as nitrogen oxides and 
volatile organic compounds react in sunlight.  Ground level ozone is harmful to human health.  
Ozone causes breathing problems and reduced lung function and aggravates asthma and other lung 
diseases.  The World Health Organization (WHO) recommends an ozone limit of 100 µg/m3 (50 
ppb) 8-hour concentration [5]. 
Sulphur dioxide [SO2] is emitted when fuel or raw material containing sulphur is burned or 
used in industrial processes [6].  The major source of SO2 in Canada is combustion of fuel for 
electricity generation and heating processes [6].  People with asthma have shown changes in 
pulmonary function and respiratory symptoms after SO2 exposure as short as 10 minutes. SO2 
causes inflammation of the respiratory tract and coughing, mucus secretion, aggravation of asthma 
and susceptibility to infections of the respiratory tract.  The WHO recommended limit is 500 µg/m3 
(191 ppb) for 10 minutes duration [5]. 
Nitrogen dioxide [NO2] is another gas emitted into the atmosphere from high temperature 
combustion processes such as vehicle engines, power plants, and industrial processes.  It is toxic 
and causes inflammation of airways.  The current WHO guideline value is 200 µg/m3 (53 ppb) in 
1 hour and 40 µg/m3 annual (21 ppb) [5]. 
Particulate matter, according to WHO, affects more people than any other pollutant [5]. 
Particulate pollution has health impacts even at very low concentrations [7].  The WHO 
recommended maximum limit of exposure is 25 µg/m3 in 24 hour mean for PM2.5, and  50 µg/m
3 
in 24 hour mean for PM10 [5].  
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2.3.1.2 International Comparison of Air Quality 
Figure 2.1 is an international comparison of annual urban air quality indicators for fine 
particulate matter, sulphur dioxide, ozone and nitrogen dioxide.  In 2014, China had the highest 
fine particulate matter at 30 µg/m3, about 3 folds higher than the levels found in urban areas in 
Canada (<10 µg/m3) [8].  The level of ozone pollution was ≤50 ppb in the USA, while the 
highest in Canada was <35 ppb.  Sulphur dioxide was less than 1 ppb in Canada while it was 6 
ppb in China.  Nitrogen oxide was approximately 50% less in Canada, at ~15 ppb compared to 
>35 ppb in China [8]. 
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Annual average concentrations of fine particulate matter for 
selected Canadian and international urban areas, selected years                          
 
 
 
 
Annual average concentrations of ozone for selected Canadian and 
international urban areas selected years         
                    
              
 
Annual average concentrations of sulphur dioxide for selected 
Canadian and international urban areas selected years                          
 
 
 
 
 
Annual average concentrations of nitrogen dioxide for selected 
Canadian and international urban areas selected years 
 
Figure 2-1. International comparison of urban air quality indicators. Taken from: Environment 
and Climate Change Canada (2016) Canadian Environmental Sustainability Indicators: 
International Comparison of Urban Air Quality; pp 6-9. Available at: www.ec.gc.ca/indicateurs-
indicators/default.asp?lang=en&n=FDBB2779-1. 
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2.3.1.3 Canadian and Saskatchewan Air Quality 
The annual concentration of major pollutants in Canada, nationally and regionally, for the 
year 2014 are briefly summarized in Table 2-1.  In general, the air pollutants in Canada are below 
the World Health Organization Guidelines [5].  In 2014, pollutants in southern Ontario, which is 
comprised of Toronto and Ottawa, were consistently higher than the national pollutant levels.  This 
might be due to population density in those cities.  Pollutant levels in the Prairies and Northern 
Ontario region, which includes Saskatchewan, were less than the national values. The Prairies, 
which includes Saskatchewan, has air pollution levels below the national average. 
Table 2-1. Annual concentrations of major pollutants in Canada (2014). 
 O3 (ppb) SO2 (ppb) NO2 (ppb) PM2.5 (µgm
-3) 
National levels 32.9 1.3 8.9 7.7 
Regional levels     
Atlantic Canada 32.5 1.1 4.4 6.0 
Southern Quebec 33.2 1.7 8.4 8.1 
Southern Ontario 36.6 2.4 9.8 8.3 
Prairies & 
Northern Ontario 
32.7 0.8 7.9 7.4 
British Columbia 27.7 1.3 10.5 7.3 
Source: Environment and Climate Change Canada (2016) Canadian Environmental Sustainability Indicators: Air 
Quality. Ozone, O3 - annual average of the daily maximum 8 hours average concentration; sulphur dioxide, SO2 - 
annual average of the hourly concentration; nitrogen dioxide, NO2 - annual average of the hourly concentration; 
particulate matter size 2.5, PM2.5  - annual average of daily 24 hours average concentrations; ppb - parts per billion; 
µgm-3 - micrograms per cubic metre. 
 
Figure 2-2 comprises the annual averages for major air pollutants in Saskatchewan for the 
years 2000-2016.  In Saskatchewan, air pollutants show a decreasing trend over time, with fine 
particulate matter at lower levels as compared with coarse particulate [9]. 
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Figure 2-2. Saskatchewan urban air quality concentration annual averages. Source Government 
of Saskatchewan. Air quality and emission. https://www.saskatchewan.ca/residents/environment-
public-health-and-safety/state-of-the-environment/air-quality-and-emissions. 
2.3.1.4    Canadian Air Quality Standards 
 Ambient air quality monitoring through National Air Pollution Surveillance of the 
Canadian Air and Precipitation Monitoring Network (CAPMoN) provides the foundation for air 
quality management in Canada, including the evaluation of progress relative to the Canadian 
Ambient Air Quality Standards (CAAQS).  The CAAQS are a national set of voluntary standards.  
These standards were established under the Canadian Environmental Protection Act, 1999 on May 
25, 2013.  The two pollutants that fall within the CAAQS are ozone and fine particulate matter 
(PM2.5).  The CAAQS standards are shown Table 2-2. 
 
 
 
 
 
12 
 
Table 2-2. Canadian Ambient Air Quality Standards. 
Pollutant 2015 standard 2020 standard 
PM2.5 Annual 10 g/m3 8.8 g/m3 
PM2.5 for 24-hours 28 g/m3 27 g/m3 
Ozone for 8-hours 63 ppb 62 ppb 
ppb = parts per billion 
 
2.3.2 Particulate matter as a pollutant 
2.3.2.1 Particulate matter (PM) 
Airborne particulate matter, a complex mixture of organic and inorganic substances, is an 
important component of air pollution [5].  Particulate matter exceeding 2.5 microns in aerodynamic 
diameter, but less than 10 microns (PM10) is generally defined as coarse particles, while particles 
smaller than 2.5 microns (PM2.5) are defined as fine particulate matter [10].  Fine particles have a 
greater total surface area than larger particles and typically possess a porous surface that can adsorb 
and retain toxic substances [2].  Particulate pollution is comprised of emissions from both natural 
and human activities.  Naturally, particles emerge from wind-blown dust, volcanic ash, pollens, 
soil particles, the products of forest fire and oxidation of biogenic reactive gases.  Human activities 
include fuel combustion from vehicles and power plants, industrial processes, construction work, 
quarrying and mining activities [11].  The conduct of particles in the air and within the respiratory 
system is largely determined by their physical properties which depend on size.  Particulates of 
less than 2.5 micrometres infiltrate the alveoli and terminal bronchioles while the larger size of up 
to 10 micrometres deposits mostly on bronchi and the upper respiratory tract [11]. 
2.3.2.2 Constituents of particulate matter 
The array of species localized on the surface of PM act as catalysts in the health effects 
associated with ambient PM [11].  The composition of PM varies greatly and depends on many 
factors, for instance, source, climate, season and humidity [2].  Coarse particulate matter is 
composed mainly of an insoluble crust-derived, mineral, and material of biologic origin such as 
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endotoxin.  Fine particles are made up of carbonaceous aggregates with metals and organic species 
adsorbed on the surface cavities [2]. 
2.3.2.3 Factors affecting deposition of particulate matter 
Particulate size and shape in conjunction with size and dimensional characteristics of the 
respiratory tract influence the deposition of particles [11].  Particle settlement on the respiratory 
tract is guided by three main mechanisms, the first of which is impaction which regulates the 
deposition by the use of speed and mass inertia of the particulate matters.  Large particles have the 
greatest chance of impacting the large respiratory tract by colliding with the airways wall.  The 
smallest particles with smallest mass are capable of following the main stream of airflow to 
branching airways [12].  The second mechanism is sedimentation which is the process by which 
the particles fall down due to gravitational effects in the airway tracts.  The speed at which a 
particle drops is relative to its density and to the square of its diameter.  At the lower tract and 
alveoli, Brownian diffusion (third mechanism), which is the motion due to the kinetic energy of a 
particle, becomes the primary mechanism contributing to particle deposition due to linear velocity 
and mass flow approaching zero [13]. 
When large particulate matter of 10 micrometres or greater is inhaled, it usually ends on the 
walls of the nose and pharynx [11].  These parts of the body are effective in clearing the inhaled 
air of the suspended particles and in turn reduce the volume of large particles at the lower airways.  
Most of the inhaled particulate matter in the diameter range of 2.5 to 10 micrometres are believed 
to deposit on the tracheobronchial surface while deposition at the alveoli level occurs with particles 
in the range of 0.1 to 2.5 micrometres [13]. 
2.3.3 Endotoxin as a component of particulate matter 
Toxicity of particulate matter on the respiratory tract depends on the size and composition 
of the particulate.  Size determines the degree of penetration into the tract and the composition of 
the particulate contributes to the PM-induced health effects [11,14].  The most significant 
macromolecule adsorbed on the surface of organic particulate matter is endotoxin [15], therefore 
it is imperative to evaluate levels of endotoxin in particulate matter.  For example, the role of 
endotoxin becomes clearer by the results of a study conducted in three regions of Mexico City.  
The study showed that PM10 in the presence of endotoxin, induced interleukin 1 beta (IL-1β), a 
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cytokine protein which is as an important mediator of inflammatory response [16].  Huang et al., 
2002, found in their study that presence of endotoxin in PM2.5 and PM10 was responsible for 36% 
and 24% production of tumor necrosis factor alpha (TNF-, a cell signal protein which involved 
in systemic inflammation respectively [17].  Similarly, another study on endotoxin and PM showed 
a 30-fold macrophage inflammatory proteins production, which is crucial in the development of 
inflammation [18].  Given that Saskatchewan has low population density with agriculture as its 
predominant industry, ambient particulate pollution from organic particulate matter, and therefore 
endotoxin is an important consideration.  Endotoxin is the most significant component of 
particulate matter in grain dust, and is associated with the development and aggravation of airway 
diseases in working populations [15].  In the absence of cigarette smoke, significant levels of 
endotoxin in domestic environments may relate to respiratory disease severity [19].  The levels of 
endotoxin can be thousands times higher in a high exposure environment, such as agricultural, 
compared to non-direct exposure environment, such as outdoor air, and based on distance to the 
source [20]. 
2.3.3.1 Endotoxin  
Endotoxin is a complex chemical component of the outer membrane of Gram-negative 
bacteria, and plays an important role in cell integrity and interaction of the cell with the 
extracellular environment [21].  Organic matter Gram-negative bacteria are found in either solid 
(e.g. settled dust, household waste, plants) or liquid (e.g. waste-water, metal working fluids, 
waterlines) mediums [21].  Endotoxin is released into the air during cell growth and after 
occurrence of bacteria’s death [22].  It can stay in the air for long periods of time due to its small 
size [23].  
2.3.3.2 Chemical structure of endotoxin 
Endotoxin is an integral part of cell walls and is made of thermostable lipopolysaccharide, 
(LPS), proteins, and phospholipids [24].  Lipopolysaccharide is further made up of Lipid A, 
polysaccharide nucleus, and polysaccharide chains (Figure 2-3).  Lipid A is similar in all species 
of bacteria and is responsible for the toxic effects of endotoxin [25].  Endotoxin derives its strength 
from the polysaccharide nucleus while polysaccharide chains are responsible for immunogenicity.  
The toxin is resistant to heat and heating at 180oC over 4 hours is recommended for sterilization 
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[25].  Three forms of endotoxin are present in the air: a pure form consisting of small 
lipopolysaccharides molecules having molecular weights of 2000 to 20000 Dalton; a second form 
is pure lipopolysaccharides associated with cell wall components measuring less than 1 or 2 µm; 
a third form which is associated with biological and/or non-biological aerosol particles.  The last 
two forms are generally considered to be more prevalent in the environment [26].  
 
                            
Figure 2-3. A general structure of lipopolysaccharides (LPS).  [Taken from Radon (2006); 
reproduced after obtaining written permission] [27]. 
The structural differences in the chemical nature of endotoxin influence its biological 
activity [28].  A study showed that LPS from Pseudomonas aeruginosa is distinctly less toxic 
compared to Enterobacterial LPS due to the number of acyl-groups in the Lipid A, particularly 
the hexaacyl and pentacyl groups [29]. 
2.3.3.3 Measurement of endotoxin 
Endotoxin is mostly measured in term of associated biological or non-biological aerosol in 
an environment.  Endotoxin can be measured in two forms.  The bioactive form of endotoxin is 
identified as being responsible for respiratory challenges while total endotoxins are comprised of 
those still embedded in the bacteria cell wall and the bioactive form.  Bioactive endotoxin can be 
quantified by assays such as the Limulus Amoebocyte Lysate (LAL) assay [21].  This assay is 
based on an enzymatic coagulation of the blood of a primitive marine arthropod, the horseshoe 
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crab, in the presence of endotoxin [26].  The assay measures the endotoxin potency based on the 
fatty acid content of Lipid A, the polysaccharide content, and the aggregation properties [30]. 
The LAL is sensitive for measuring low endotoxin levels less than 10 EU/m3, such as that 
found in slightly contaminated exposed environment such as outside air [31].  Variation in 
endotoxin determination can be impacted by a number of factors including the solution used in the 
extraction, the extraction methods, and the interference of beta-1,3-glucan [32, 33], and inter-
laboratory variation [34, 35].  Other methods, including a chemical analytical method utilizing gas 
chromatography- mass spectrometry, have been utilized to detect both biologically active and 
inactive endotoxins, but have been found to be less sensitive [36].  
2.3.3.4 Limulus amebocyte lysate assay 
The most common endotoxin measurement, and the one used in this thesis study, is LAL 
assay.  In this assay a sample is mixed with LAL reagent in an incubating plate and read over time, 
using a plate reader (spectrophotometer), for the appearance of a yellow colour.  The assay is 
described in detail in Chapter 4.  The reaction is composed of three serine protease zymogens and 
one clottable protein (coagulogen).  As shown in Figure 2-4, in the presence of endotoxin, a 
glycoprotein of 123 kDa, called Factor C is autocatalytically activated to active Factor C. Factor 
B, the second serine protease zymogen, is activated by active Factor C by limited proteolysis. 
Active Factor B activates Proclotting enzyme to clotting enzyme, which catalyzes the 
transformation of coagulogen to insoluble coagulum gels [37].  Using the initial absorbance 
reading of each well as its own blank, the time required for the absorbance to increase to 0.2 
absorbance units is considered the reaction time.  The reaction time is inversely proportional to the 
amount of endotoxin present.  The more the quantity of endotoxin the shorter the reaction time and 
vice versa.  The amount of endotoxin in unknown samples is referenced to a standard curve which 
is prepared on the same plate as the known samples.  Logarithmic (log/log) linear correlations are 
used to compute endotoxin levels in unknowns.  The assay is typically optimized to be linear in 
the range of 0.005 EU/mL to 50.0 EU/mL [37]. 
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Endotoxin (LPS)  
Factor C              Activated factor C 
                Factor B                       Activated Factor B 
                         Proclotting enzyme                     Clotting Enzyme 
                                               Boc-Leu-Gly-Arg +pNA                  Boc-Leu-Gly-Arg + pNA 
                                                    (Artificial substrate) 
Figure 2-4. Summary of Limulus protease activation pathway.  Taken from: 1,3-Beta-D-Glucan 
Detection Reagent Kit Manual, Cambrex, March 2007. 
2.3.3.5 Endotoxin limit 
Despite the observed occupational exposure effects on the health of workers, an exposure 
limit for endotoxin is not yet established.  The indoor, outdoor or workplace safe range of 
endotoxin exposure is still inconclusive.  In an occupational exposure study done on a poultry 
farming, Donham et al. recommended an exposure limit of 14 EU/m3 for total endotoxin and 7.15 
EU/m3 for respirable endotoxin [38].  Rylander also calculated the limit of exposure to be 33 ng/m3 
[39].  Different methods of sample collection, extraction methods, inter-laboratory procedures, 
sample storage time before analysis or transport [28, 32-33], and lack of correlation between data 
makes it impossible to establish a clear dose-effect relationship or an exposure limit for humans 
[40].  Studies commonly reference the Dutch Expert Committee on Occupational Standard’s 
recommendation of an exposure limit of 50 EU/m3 in a working environment for a period of 8 
hours [41-44]. 
2.3.3.6 Distribution of endotoxin on particulate matter 
Endotoxins have been measured in ambient particulate size matter PM2.5 and PM10 [45-47]. 
The size distribution of aerodynamic particles of airborne endotoxin plays a vital role in 
determining endotoxin toxicity and its health effects [48]. A summary of ambient endotoxin 
assessment in varying locations worldwide can be found in Table 2-2, spanning a period of 13 
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years (2001- 2014).  A majority of the studies were performed in Europe, Asia and in North 
America. 
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Table 2-3. Summary of ambient endotoxin measured in different studies. 
 Authors (Year 
published) 
Location and 
country 
Total 
number of 
samples 
Seasons/year of 
study 
Levels of ambient endotoxin  Comments 
Long et al., 
(2001) [49] 
Massachusetts, 
USA 
 13 Spring-summer 1998 
Fall-winter 1998 
PM2.5   2.0 EU/mg Seasonal variation was not 
considered 
Heinrich et al., 
(2003) [47] 
Sachsen-Anhalt, 
Germany 
21 Jan- June 2002 1st  City : PM2.5 0.8 EU/mg, 0.006 
EU/m3 ; PM10 11.7 EU/mg, EU/m3 
0.063 
2nd City: PM2.5 0.7 EU/mg, 0.008 
EU/m3 ; PM10 10.7 EU/mg, EU/m3 
0.071 
Probably the similarities of 
weather in first and second city 
drive the correlation between 
both areas 
Mueller-Anneling 
et al., (2004) [31] 
California, USA 104 1-year sampling PM10 0.44 EU/m3 
PM10 13.6 EU/mg 
Other pollutants did not affect 
the level. High in summer 
Morgenstern et 
al., (2005) [50] 
Munich, Germany 206 March 1999 to July 
2000 
PM2.5 1.30 EU/mg, 0.019 EU/m3 ; 
PM10 3.91 EU/mg, EU/m3 0.081 
 
No clear spatial pattern of 
endotoxin due to site selection 
Menetrez et al., 
(2007) [51] 
 
North Carolina, 
USA 
342  August 2003 to 
January 2004 
PM2.5 0.15 EU/m3; 0.016 EU/µg 
PM10 0.16 EU/m3; 0.045 EU/µg 
No seasonal variation 
Traversi et al., 
(2010) [52] 
Piedmont (Turin) 
Italy 
116 January 2007 to 
December 2007 
 
 
 
 
 
In PM10: 
Winter 5.02 EU/mg 
Spring 13.30 EU/mg 
Summer 16.41 EU/mg 
Autumn 7.49 EU/mg 
Levels associated with 
temperature and wind while 
inversely correlated with 
humidity 
  
 
2
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Allen et al.,(2011) 
[46] 
British Columbia, 
Canada 
City A: 226 
City B: 234 
October 2005 to 
September 2006. 
  
 
City A: PM2.5 0.15 EU/m3; PM10 
0.40 EU/m3 
City B: PM2.5 0.16 EU/m3; PM10 
0.67 EU/m3 
High temperature and moderate 
relative humidity. Wind 
direction has no effect 
Highest level of endotoxin in 
summer and fall while the 
lowest in winter and spring 
Nilsson et al., 
(2011) [45] 
Stockholm, 
Sweden 
35 May to September 
2009 
PM2.5 0.015 EU/m3;2.2 EU/mg 
PM10 0.05 EU/m3; 3.7 EU/mg 
No clear effects of traffic or 
meteorological factors 
Wheeler et al., 
(2011) [82] 
Regina, Canada 179 January-March, and 
June –August, 2007 
PM10  
Summer 1.57 EU/m3; 0.18 EU/µg 
Winter    0.12 EU/m3; 0.05 EU/µg 
 
Use of air conditioning and fan 
might influence the source of 
endotoxin 
Cheng et al., 
(2012) [36] 
Pearl River Delta 
Region, China  
City 1: 68 
City 2: 34 
City 3: 32 
February 2008 to 
March 2009 
City 1: PM2.5 0.085 EU/m3 
City 2: PM2.5 0.148 EU/m3 
City 3: PM2.5 0.099 EU/m3 
 
City 1: PM10 0.345 EU/m3 
City 2: PM10 0.386 EU/m3 
City 3: PM10 0.350 EU/m3 
City2 is an urban city with 
different manufacturing 
industries and sampling site was 
situated on the 23-storey 
building 
Guan et al.,(2014) 
[53] 
Beijing, China 321 March 2012 to 
February 2013 
In PM2.5:0.65 EU/m3; 10.25 EU/mg Levels vary with meteorological 
influence e.g., temperature 
showed positive correlation in 
winter but negative correlation 
in spring, summer and autumn 
 
   
21 
 
The studies presented in Table 2-2 were conducted prior to 2013 in large, urban metropolitan 
areas, as well as interior mainland (BC Canadian study), rural areas, and villages around the world.  
Results are reported in endotoxin units of mg or µg of particulate and/or cubic metre of sampled 
air.  Outdoor sampling sites varied from backyards of residential buildings to tops of multi-storey 
buildings (5-23), and sampling season varied.  Nilsson et al., [45] studied urban endotoxin air in 
Sweden and impact of traffic with other meteorological factors.  The study was comprised of five 
study sites.  The study showed that endotoxin ranged from 0.015 EU/m3 to 0.1 EU/m3 in particulate 
size 2.5 and 10, while traffic and meteorological factors had no observable effects on the endotoxin 
level.  In each of the sampling units, the endotoxin level found in PM10 was higher than in PM2.5.  
A study from two communities in British Columbia, Canada, found a higher concentration of 
endotoxin in PM10 than in PM2.5 in both communities [46].  The reason for this is not clearly 
understood.  These outdoor levels of endotoxin are generally less than 50 EU/m3, below the 
occupational level recommended by the Dutch Committee for occupational exposures.  The depth 
of penetration and behaviour of endotoxin in the human respiratory system is strongly influenced 
by their size of PM [54, 55].  Measuring the distribution of endotoxin in aerodynamic fractions of 
particulate is important step in determining toxicity and health effects. 
2.4 Respiratory outcomes and ambient air pollution 
2.4.1 Respiratory health measurements  
2.4.1.1 Questionnaires 
When measuring respiratory health in adults and children, certain measures have been 
commonly used in various studies, this includes questionnaires and diary to assess symptoms and 
objective testing measures such as spirometry to assess airflow or airflow obstruction [56]. 
Questionnaires are widely used in respiratory health epidemiological studies.  The presence and 
absence of symptoms or diseases can be assessed and defined depending on the information 
collected.  This method is cheap, safe, non invasive, and requires little time of the participant [57].  
The main challenge of using questionnaires is accurate recall of the participant which might be 
influenced by psychosocial and social factors [57]. 
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2.4.1.2 Spirometry 
Spirometry is one objective measure of lung function.  Lung function is an excellent 
operative marker of the effects of air pollution in the general population [58].  It is objective, 
quantitative, and an early predictor of cardiorespiratory morbidity and mortality [59, 60].  Lung 
function testing has the capacity to measure volume and airflow and can be performed using a 
spirometer [61].  The measurement records the volume of air exhaled and how quickly air is 
exhaled over a period of time [61].  Spirometry can be used to evaluate and diagnose a wide range 
of lung diseases, to measure the severity of these conditions, and to evaluate efficacy of treatment 
of lung disease [62].  Some of the maneuvers with spirometry measure passive regular breathing, 
while others require forced exhalation after a deep breath.  Training on appropriate maneuver 
techniques improves the quality of the measures and minimizes error due to technique. 
Lung function testing through spirometry is performed in a standardized fashion.  There are 
specific guidelines that allow for this standardization and reproducibility of results and to reduce 
variability from the use of different techniques or equipment.  The American Thoracic Society and 
the European Respiratory Society have developed such guidelines [61].  There is a standard to 
ensure appropriate equipment assessment and maintenance, spirometry calibration, and number of 
spirometry maneuvers performed [63].  A maximum of eight spirometry maneuvers should be 
performed and at least three minimum attempts.  It is important to be able to identify if adequate 
spirometry is performed in order to be able to utilize the ensuing data appropriately.  Recognizing 
the limitations and quality of lung function testing allows for proper understanding and use of the 
spirometry results [39].   
Several studies have ascertained that spirometry parameters are good indicators to know the 
state of lung function.  Maximum forced vital capacity (FVC) and maximum forced expiratory 
volume in 1 second (FEV1) is commonly used parameters in research studies as the early pointer 
of chronic respiratory and systemic inflammation [64, 65].  Important factors in lung function 
include: height, sex, age, ethnic background and smoking history [66]. 
2.4.1.3 Factors affecting spirometric measurement 
Height is a crucial factor that affects the expected lung volume [67].  The taller the 
individual, the higher the lung volume.  The disparity found with lung volume increases with 
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age.  Lung volume rises as the lungs develop from birth to 20 years of age in females, and 20 to 
24 years of age in males [67, 68].  Subsequently, lung capacity drops with age because the lungs 
lose elastic recoil with reduced expiratory flows [67, 68].  Adult males have higher lung volumes 
than adult females of the same age and height.  African Americans have lung volumes 
approximately 10% lower than Caucasians while Asians have lung volumes 2% to 8% lower 
than Caucasians [69]. 
2.4.1.4 Spirometric parameters 
Important measurements of lung function can be obtained using spirometry through the 
forced expiratory measurements [62].  These include forced vital capacity (FVC), forced 
expiratory volume (FEV1), peak expiratory flow (PEF),  and forced expiratory flow between the 
25th and 75th percentile of FVC (FEF25-75%).  FVC measures the volume of air one can exhale 
forcefully after deep inhalation.  PEF measures how quickly the breath is exhaled.  FEV measures 
the volume of air one can forcefully exhale in one breath over a measured time, typically in the 
first second (FEV1) [56,66].  The ratio of FEV1 and FVC (FEV1/FVC) can provide a useful 
measure for evaluating obstructive and restrictive lung disease.  FEV1 is regarded as the typical 
measurement to detect airflow caliber.  This index shows the quality of both large and small 
airways [55].  A decrease in ratio resulting from a decreased FEV1 is seen with obstructive lung 
disease, which would have a reduced (FEV1/FVC) ratio.  In restrictive lung disease, both FEV1 
and FVC are reduced, so the ratio may be normal or even increased [70]. 
Lung function measures can be interpreted through absolute and percent predicted values.  
Absolute values of lung function are the recorded measurements from spirometry for a patient or 
individual.  Predicted values of lung function are calculated based on age, sex, and height of a 
patient, which is typically, based on large population studies of healthy none smoking patients 
[62].  Lung function is expressed as a percentage of the predictive value by comparing the absolute 
value to the predicted value.  This allows classification of the severity of impairment in lung 
function relative to a ‘normal’ population [62,68]. 
Repeated spirometry testing is useful to assess patterns or changes including progression in 
disease status, medication change requirements, or changes as a result of exposures such as 
occupational or environmental. 
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Portable spirometry meters, such as PIKO-1 are commonly used when repeated measures 
over time for the same subject are required, particularly in the home setting.  The value of this 
functional, affordable, high quality, portable measuring device has been fully recognized [71].  
This small device measures peak expiratory flow (PEF) and FEV1.  The device is capable of date 
and time stamping measures, and able to store up to 96 measurements with an FEV1 range from 
0.15 to 9.99 and an accuracy of ±3.5% (0.05 L) [72]. 
2.4.2 Global burden of air pollution 
The impact of exposure to very high levels of particulate pollution is well documented.  
However, there is a significant discourse on the impact of low level particulate pollution exposures.  
Globally, air pollution is a major health risk, including increased risk of heart disease, stroke and 
lung cancer.  Air pollution is attributed to 5.5 million premature mortalities worldwide, or one in 
10 deaths, the fourth leading mortality risk in the world.[73]  A recent report on the health impacts 
of air pollution in Canada estimates 14,400 annual mortalities attributed to air pollution [74]. 
Epidemiological studies have shown associations between airborne particles and respiratory 
health problems [59,75-76].  Cohen et al., [77] studied the global burden of disease due to outdoor 
air pollution in 2005.  The analyses of the study were based on fine and coarse particulates which 
showed that these exposures accounted for 3% of adult cardiopulmonary disease mortality and 5% 
of respiratory tract cancer [77]. 
The health response to particulate pollution varies between individuals and subgroups of 
the population.  Individual vulnerability affects the level at which health effects are observed or 
the rate of increase in symptoms as the pollution increases.  Factors that increase vulnerability 
include underlying chronic respiratory or cardiovascular condition [78] and metabolic diseases 
[79].  Children and the elderly are highly susceptible to air pollutants.  Children are susceptible 
due to higher metabolic rates, spending more hours outside the house, and a developing immune 
system.  The elderly population is susceptible to adverse effects of air pollutants because of a less 
efficient immune system, decrease in chest wall compliance, and functional decline of organ 
systems [80-84].  Epidemiological studies have demonstrated a strong association between 
exposure to air pollution and respiratory health [59].  Low to moderate levels of ambient air 
pollutants can greatly increase respiratory problems in older adults [14].  For instance, Ye and co-
workers (2001) studied adult residents in Tokyo, Japan for 15 years in relation to particulate matter 
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pollution.  They found that increasing airborne outdoor PM10 concentrations were associated with 
significantly higher rates of asthma and bronchitis with p-value less than 0.0001 [85]. 
2.4.2.1 Burden of respiratory outcomes in Canada and Saskatchewan 
Respiratory disease is a vast worldwide health problem.  Respiratory symptoms and disease 
are common and the prevalence increases with age [86].  In general, and including tuberculosis, 
pulmonary hypertension, and other occupational lung diseases, more than 1 billion people are 
suffering from chronic respiratory conditions [87].  Asthma is the most common chronic disease 
locally and globally.  It is estimated that approximately 250 million people worldwide suffer from 
asthma [89], more than 200 million people suffer from COPD [88], and as much as 6% of the adult 
population experience sleep-disordered breathing [88]. 
According to Public Health Agency of Canada (PHAC), tobacco smoking and air quality 
(indoor and outdoor) played the foremost role in the development and exacerbation of respiratory 
illnesses in Canada [90].  According to the Canadian Lung Association, one in every five 
Canadians, both adults and children, has a respiratory problem.  A disease associated with the lung 
is the third leading cause of death among Canadians [91].  In comparison with other developed 
countries, prevalence of asthma and asthmatic-like symptoms in Canada (14.1%) is somewhat 
similar to United States (10.9%) and very similar to United Kingdom (>15%), New Zealand 
(15.1%), Australia (14.7%) and the Republic of Ireland (14.6%) [92]. Overall, in the North 
American population one-tenth has asthma [92].  According to Canadian Community Health 
Survey (CCHS) of 2005 adults over the age of 34 surveyed, 4.4%  reported that they had been 
diagnosed by a health professional with COPD (includes self-report of COPD, chronic bronchitis 
or emphysema) [93].  Lung cancer is the leading cause of death due to cancer in Canada.  It causes 
approximately 29% of cancer deaths among men and 22% among women. In 2007, an estimated 
23,300 Canadians were expected to develop lung cancer [94].  In 2005, 1,616 cases of new and 
relapsed active cases of tuberculosis were reported in Canada (5.0 per 100,000).  The incidence 
rates were highest among the 65-74 and 75 and over age groups [95].  In general, 3 million 
Canadians are dealing with one of the five serious respiratory diseases – asthma, chronic 
obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), and cystic fibrosis.  These 
and other respiratory diseases affect individuals of all ages, cultures and backgrounds from 
children to parents to grandparents [96]. 
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In Saskatchewan, in 2005, an estimated 8.8% of the adult population had been diagnosed 
with asthma [97], while COPD was estimated to be 4.3% [98], lung cancer incidence 53.7 per 
100,000 population [99] during the same year.  According to Saskatchewan provincial 
tuberculosis working group in 2013, the rates of tuberculosis in Saskatchewan are higher than 
national rates, with 7.5 cases per 100,000 people in Saskatchewan compared to the Canadian 
average of 4.7 per 100,000 [100]. 
The problem of respiratory illness is substantial in Canada [91].  Asthma and related 
respiratory health problems put remarkable limitations on all aspects of life including physical, 
emotional, social, economical and professional characteristics of an individual especially in the 
absence of proper treatment [101].  According to the Conference Board of Canada, in 2010 the 
burden of lung diseases was about $3.4 billion in term of direct health care costs while $8.6 billion 
was spent on indirect expenses [102].  A panel survey between 2002 and 2007 in the United States 
attributed a total cost of $56 billion to asthma [103].  The Lung Association of Canada projected 
annual economic liability to increase two-fold by 2030 if no strategy was devised to cope with the 
respiratory disease [104].  A substantial portion of this burden could be alleviated through 
improvement in ambient air quality [105]. 
2.4.3 Respiratory outcomes and the role of endotoxin 
2.4.3.1 Respiratory outcomes 
Respiratory disease is a pathological process with characteristic sets of signs and symptoms.  
Several factors impact respiratory outcomes and disease including personal (age, sex, genetics and 
smoking) and environmental factors (damp housing and environmental exposures) [83,106].  
Respiratory disease is common in both adults and children and accounts for a great deal of personal 
and health care burden.  The most common respiratory diseases include asthma, chronic 
obstructive pulmonary disease, lung cancer, influenza and tuberculosis [107].  Respiratory 
symptoms are subjective evidence and phenomenon that is experienced by an individual affected 
either as a precursor to disease or as a component of the disease state [86]. Common respiratory 
symptoms include wheezing, chest tightness, cough, phlegm, and shortness of breath [86].  
Respiratory symptoms are mostly characterized as acute or chronic.  Acute is when a 
condition is rapid in onset and subsiding after a relatively short period.  Chronic respiratory 
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conditions persist for a longer time period (typically categorized as greater than 3 months) and 
exhibit slow progression [106,107].  The symptoms can present as partially reversible airway 
obstruction, airway inflammation, and/or airway hyperresponsivesness [106].  Allergic 
respiratory conditions are caused by hypersensitivity of the immune system to something in the 
environment (allergen).  The conditions include hay fever, allergic asthma and sinusitis while the 
allergic respiratory symptoms include sneezing, coughing, phlegm, wheezing, shortness of breath 
[107].  Respiratory and associated sputum production symptoms are important markers of 
developing acute or chronic respiratory diseases in adults [86]. 
The presence of symptoms can reflect irritation, inflammatory conditions, and/or respiratory 
disease.  The respiratory tract develops signs when stimuli trigger a reaction on the smooth surface 
of the respiratory tract [106].  According to World Health Organisation (WHO) 2008, respiratory 
diseases are commonly characterized by swelling of bronchial tubes, causing narrowness of 
airways and breathlessness in a severe condition [89].  Several mechanisms have been suggested 
to explain the adverse respiratory effects of air pollutants.  The common path of action is that when 
an air pollutant (such as particulate matter, ozone, and nitrogen oxides) rests on the respiratory 
epithelium, high concentrations of oxidants and pro-oxidants cause the formation of oxygen and 
nitrogen free radicals which induce oxidative stress.  Non-neutralized free radicals by antioxidant 
defences start an inflammatory response and mediators that result in subclinical inflammation [5, 
104]. 
2.4.3.2 Endotoxin and respiratory outcomes 
Endotoxin enters the respiratory system through inhalation, which causes respiratory and 
systemic inflammatory responses including dry cough and decrease in lung function [21,32]  
Several studies have revealed that inhalation of bioactive endotoxin can trigger an immunological 
response and cause inflammation [108].  The lipid A part of bioactive endotoxin, after deposition 
on the respiratory tract, encounters alveolar macrophages carrying CD14 gene, which serves as 
receptor for LPS. Through tissue receptors, the macrophages are activated leading to release of 
pro-inflammatory cytokines, chemokines, and other mediators [109,110].  
Mediators released as a result of endotoxin include TNF-, IL-1β, IL-6 and IL-8 [109].  
These cytokines trigger the assembly of neutrophils that result in local and systemic inflammation 
[109,110].  Individual genetic make-up is known to be accountable for how individuals respond to 
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endotoxins [111].  These immunological changes are minimal in a normal individual but more 
obvious in asthmatic subjects, which mean inhaled endotoxin may worsen respiratory health 
effects in individuals with underlying respiratory symptoms [112].  
In some previous studies, endotoxin exposure has been considered to have protective effects, 
particularly in children.  These studies suggested that early life exposure to endotoxin causes 
secretion of inflammatory cytokines which is responsible for maturation of immune system in the 
direction of T-helper cell 1, subduing the risk for atopic sensitization [27].  In a study that involved 
61 infants at high risk for sensitization, it was found that the risk for atopic sensitization was 
inversely associated with the concentration of endotoxin in the house dust [113].  Another study 
in the USA by Perzanowski et al., 2006, found that exposure to endotoxin may reduce risk of 
developing childhood atopy [114].  In an association with wheeze and asthma among the children 
dwelling in the rural area, the exposure to endotoxin might be protective [115]. 
Studies of associations between endotoxin and respiratory health effects (1998 - 2015) are 
summarized in Table 2-3.  In this summary, only the spirometry values were tabulated as the 
findings.  Most of the studies were performed in Europe, Asia, and in North America and the 
majority examined exposed working populations rather than the public.  As shown, endotoxin 
was found to be associated with respiratory effects (lung function; FEV1, PEF, FVC). 
The studies were mostly conducted in workplaces, schools, and among workers and students.  
Endotoxin sampling included personal aerosol sampling and indoor area sampling.  The duration 
of exposure in the articles reviewed ranged from 1 month to 25 years.  At the time of developing 
this thesis, the author could not found a research article that considers association between ambient 
endotoxin and respiratory outcomes of FEV1.  In general, exposure to endotoxin in a closed 
environment affects FEV1 at different concentrations and this may be attributed to the duration of 
exposure. 
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Table 2-4. Overview of studies of associations between endotoxin and lung function health effects (1998- 2015). 
Authors 
(year 
published) 
Country Study 
population 
Outcomes 
variables 
Findings Other comments 
Thorn & 
Rylander, 
(1998) [112] 
Sweden Healthy 
subjects 
Questionnaire for 
symptoms, 
spirometric testing 
and blood 
sampling 
FEV1 and FVC values were 
significantly lower 24 hours after 
inhalation of LPS. 
Non-smokers, no current cold, no 
asthma 
Vogelzang et 
al.,(1998) 
[116] 
Netherlands  Pig farmers Spirometric 
parameters: FEV1 
and FVC 
After adjusting for age, baseline 
parameters and smoking, decline in 
FEV1 & FVC was strongly associated 
with endotoxin exposure at annual 
mean of 105 ng/m3 of endotoxin. 
 
Kirychuk et 
al., (1998) 
[117] 
Canada Swine 
workers 
FEV1 and FVC  No statistical significant association 
was found between annual FEV1 or 
FVC decrease and airborne endotoxin 
The observation might be due to 
sample size 
Wang et al., 
(2003) [118] 
China Young female 
cotton 
workers 
FEV1 and FVC Decline by 2% in FEV1 & FVC after 3 
months, 5% in FVC after 12 & 18 
months, 2.8 % and 1.3% after 12 
months and 18 months respectively 
Newly hired, the parameters were 
compared to their first day at work 
Sigsgaard et 
al., (2004) 
[119] 
Denmark Male paper 
mill workers 
FEV1 and FVC Changes were observed in FEV1 and 
FVC every year 
 
Rabinovitch 
et al., (2005) 
[120]  
USA Asthmatic 
school-aged 
children 
FEV1 and asthma 
symptoms 
Increases in personal endotoxin 
exposures were associated with 
decreased FEV1 values and increased 
symptoms 
Personal monitoring. 
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Mehta et al., 
(2010) [141] 
China Cotton textile 
workers 
FEV1 and 
respiratory 
symptoms  
Among all the workers, there were 
strong association with reduced FEV1 
especially with workers hired less than 
5 years 
Likewise, the association was found 
chronic cough 
Lawson et 
al., (2011) 
[122] 
Canada School-aged 
children 
Questionnaire for 
symptoms and 
spirometry: FEV1 
and FVC 
High concentration of endotoxin on 
the mattress was associated with 
decline FEV1 (β = -0.25, SE=0.07 
(p<0.01) among the female case 
group, while similar associated was 
found play area with FVC β= -0.17, 
SE=0.09 (p<0.10) 
Sex and tobacco smoking influence 
the association 
Cyprowski et 
al., (2015) 
[123] 
Poland Sewage 
treatment 
plant workers 
FEV1 and FVC Despite the low endotoxin levels, 
significant impact was observed on 
across-shift FEV1  
The result was independent of dust 
concentrations and smoking habits 
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2.4.4 The Air Quality Health Index (AQHI) for communicating risk from air pollutants 
Tools have been developed as a means of communicating the potential health risks of air 
pollution to the general public.  The Air Quality Health Index (AQHI) is a communication tool 
which is used in Canada to quantify the level of risk from short-term exposure to air pollution 
[7,124].  The tool uses three pollutants to calculate a single numerical value as the indicator of 
health risk: PM2.5, NO2, and ground level ozone O3 [124,125].  AQHI indicates the health risk 
from pollution in a scale from 1 to 10.  The health risk is classified in categories for the general 
population by the index as, low risk (1 to 3, ideal), moderate risk (4 to 6, modify activities if 
symptomatic), high risk (7 to 10; modify outdoor activities to reduce exposure) and very high risk 
(above 10; reduce outdoor activities) [125].  These risks are altered for at-risk populations 
including those with pre-existing disease, children and the elderly (low risk is 1 to 3, enjoy; 
moderate risk is 4 to 6, consider modifying activities; high risk is 7 to 10; reduce outdoor activities; 
and very high risk is above 10, avoid outdoor activities) [125]. 
2.5 Summary and gaps from the literature 
The thesis literature review discussed research studies on endotoxin as a biological 
component of particulate matter, its method of detection and its effect on respiratory health. 
Occupational exposure to endotoxin and its association with both respiratory and systemic 
pathologies has been well studied as have endotoxin levels in indoor environments.  However, 
very few studies have measured ambient levels of endotoxin, particularly in Canadian rural areas.  
In addition, and despite, the association between inhaled endotoxin in agricultural settings and 
respiratory health, very little research on ambient endotoxin levels has been conducted in rural 
area settings.  The study setting was based on prior knowledge, including differences in asthma in 
children in the two rural study sites.  Therefore, this study addresses the need for more knowledge 
regarding endotoxin levels in rural communities, especially in agriculturally intensive areas with 
additional industrial operations.  Assessing ambient endotoxin levels and possible association with 
lung function may add important information in this area, particularly for rural Saskatchewan, and 
this defines the importance and novelty of the thesis topic. 
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2.6 Objectives of the study 
The objectives of this study were to (1) determine the level and distribution of endotoxin in 
ambient particulate samples of different sizes (PM2.5 and PM10) obtained from two rural 
communities (Estevan and Swift Current, Saskatchewan, Canada) and (2) to examine the 
association between endotoxin levels in the particulate size fractions (PM2.5 and PM10) and 
respiratory outcome (FEV1) among a sample of adult residents (50 years and older) in Estevan and 
Swift Current. 
2.6.1 Research Questions and Hypotheses 
1. What is the concentration (EU/m3) and load (EU/µg) of endotoxin in particulate matter (PM2.5 
and PM10) in the communities of Estevan and Swift Current? 
2. What is the variation in ambient endotoxin distribution in particulate matter (PM2.5) and 
(PM10) and does this differ between Estevan and Swift Current? 
Hypothesis 2-1: There are differences in endotoxin levels (concentration and load) between 
PM2.5 dust and PM10 dust within each community and each phase. 
Hypothesis 2-2: There are differences in endotoxin levels (concentration and load) in PM2.5 
and PM10 between each community and each phase. 
3. What is the association between ambient endotoxin levels (concentration and load) and the 
forced expiratory volume in 1 second (FEV1)? 
Hypothesis 3-1:  Ambient endotoxin levels (concentration and load) in PM2.5 and PM10 
are associated with FEV1 by community. 
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CHAPTER 3 METHODOLOGY 
3.1 Overall study methodology 
This thesis is a component of a larger study conducted by the Airways Research Group and 
is in furtherance of previous research by members of the Airways Research Group that studied the 
prevalence of asthma in children in these two rural communities and reported higher prevalence 
in Estevan compared to Swift Current [1].  The larger study aimed to assess the impact of airborne 
environmental contaminants on respiratory public health in Saskatchewan.  The thesis herein 
incorporates only the particulate endotoxin levels and the population measures of FEV1 from the 
larger study. 
The study has two parts that were conducted simultaneously: a population study and an 
environmental study.  The study was conducted between 2012 and 2014: fall 2012 (phase 1), spring 
2013 (phase 2), fall 2013 (phase 3) and spring 2014 (phase 4).  Due to technical difficulties with 
sample collection in the fall of 2012, phase 1 was not included in the thesis and therefore for the 
thesis the phases were renamed as follows: spring 2013 (phase 1), fall 2013 (phase 2), and spring 
2014 (phase 3).  
The study was conducted in a small urban centres of Estevan, a primarily industrial (coal 
mining)-based community, and Swift Current, a predominantly agricultural-based community, 
both of which are in southern Saskatchewan, Canada.  Detailed descriptions of each community 
are presented in Manuscript 1 (Chapter 4).  
The research described in this thesis was supported by grants from the Saskatchewan Health 
Research Foundation (SHRF) and the University of Saskatchewan.  
3.2 Environmental Methods 
3.2.1 Particulate sampling 
Sampling occurred in the communities of Estevan and Swift Current over each of the study 
phases to coincide with the population data collection (Phase 1 from April-June 2013, Phase 2 
from October-December 2013 and Phase 3 from April-June 2014).  Samples were collected over 
consecutive seven-day periods (sample) for the length of each study Phase. 
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Sampling equipment was co-located with provincial air monitoring equipment with the site 
selection based on the Saskatchewan Air Monitoring Directive [2].  The site was chosen to 
represent an efficient assessment of air quality for the general public in the area taking into account 
site and power accessibility, air dispersion modelling, topographical effects, local interferences 
and security.  The sampling site in Estevan was located in the southeast of the city, on a hill, at the 
roof of a one story building, within a secure compound.  The sampling site in Swift Current was 
located in the northwest of the city, on the rooftop of a one-story provincial building near the 
highway (Figure 3-1). 
Ambient particle samples were collected on pre-weighed 25 mm polycarbonate filters 
(2.0µm, SKC Inc., Eighty-four, PA, USA) using a 2-stage (PM 2.5 and PM 10) sampler (Dekati, 
ISO 23210, Dekati Ltd, Tampere, Finland) connected to a high-volume pump (Gilian, Aircon2, 
Sensidyne, FL, USA) that ran at a flow rate of 30 L/minute.  Samples were collected over 
consecutive seven-day periods (sample) for the length of each study Phase.  One blank field filter 
was taken for each five study filters. (Figure 3-2)  The blank field filter accounted for any 
endotoxin accumulation from technical, field, and storage activities.  Due to technical difficulties, 
Phase 2 resulted in a smaller sample size collection.  Post sampling, filters were stored in their 
identity labelled storage cassettes (SKC, Concept Controls, Edmonton, AB, CA), date stamped, 
placed in a sealed labelled Ziploc bag with desiccation packs, and refrigerated at 4°C until transport 
and post-weights. 
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Figure 3-1. Map of Saskatchewan showing the communities and sampling locations. Source: 
https://www.google.ca/maps 
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          Figure 3-2. The Sampler and a Sample stage with filter. 
 
 
3.2.2 Gravimetric analysis 
The weight of filters was measured before and after sampling using a MX5 microbalance 
(Mettler Toledo, Mississauga, ON, CA) with a resolution of 0.1 µg.  Filters were stored with 
desiccation- pre and post weighing.  Before weighing, filters were equilibrated to room 
temperature and humidity for 30 minutes.  Each filter was then placed through a static neutralizer 
(PRX U Small SET, Haug Static, Richmond Hill, ON, Canada) and weighed in triplicate and the 
average of the weights (µg) was calculated for each sample (7-day collection period) for each size 
fraction (PM2.5 and PM10).  PM concentration (µg/m3) was then calculated as follows:  
                   [(W2 – W1)] *103/ V ……………………………………………………….3.1 
Where: 
W1 is the mean pre-filter weight (µg) 
W2 is the mean post-sampling weight (µg)  
V is the volume of air sampled (m3)   
 
Volume = sample flow rate (30 L/minute) * (sample time, minutes) / 1000 L/m3 
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3.2.3 Endotoxin Determination 
3.2.3.1 Filter Extraction 
Filter extractions were carried out after all samples from all phases were collected (i.e. after 
August 2014).  For extraction each filter was cut in half using a sterile scalpel blade.  One half of 
the filter was placed back in the storage container and stored in the desiccator at 4oC for other 
analyses.  The second half of the filter was immediately extracted for endotoxin analysis.  The half 
filter was placed in a 2 mL bead beating tube containing 2 g of 2 mm Zirconia beads (BioSpec, 
Bartlesville, OK, USA).  One milliliter of 0.05% Tween 20 (Fisher Scientific, Ottawa, ON, 
Canada) in endotoxin-free water (Hyclone, GE Healthcare, Mississauga, Canada) was added to 
each tube and bead beaten for 3 min at the highest setting using the Retsch MM 400 Oscillating 
Mill (Retsch, Newtown, PA, USA).  Tubes were placed in an ice box between bead beating and 
centrifugation.  The tubes were centrifuged at 13,000 rpm for 5 min (Thermo Scientific Sorvall 
Legend Micro 17 Centrifuge, Fisher Scientific, Ottawa, ON, Canada).  The supernatant was 
transferred to 1.5 mL polypropylene tubes (Fisher Scientific, Ottawa, ON, Canada) and centrifuged 
at 13,000 rpm for 10 min at 4oC (Eppendorf Centrifuge 5430R, Eppendorf Canada, Mississauga, 
ON, Canada).  Finally, the supernatant was removed, aliquoted, and stored at -80oC until endotoxin 
analysis. 
3.2.3.2 Endotoxin analysis 
Endotoxin was determined using the Kinetic chromogenic Limulus Amoebocytes Lysate 
(LAL) assay according to the manufacturer’s recommendations (Lonza, Walkersville, MD, USA).  
The steps of endotoxin analysis are attached as Appendix A.  One aliquot of sample extract was 
thawed at room temperature.  100 µL of each of undiluted sample extract, LAL reagent water 
blank, and endotoxin standards (E.coli 055:B5, five standards optimized for the range 0.005 to 50 
EU/mL), were dispensed in triplicate into 96-well plates.  The plate was then incubated in the 
ELx808 plate reader (BioTek, Winooski, VT, USA) for 10 minutes at 37oC.  After incubation, 
kinetic LAL reagent was added to each well and the plate was further incubated for another 2 
hours.  
Absorbance was monitored at 405 nm and the time required for the absorbance to increase 
to 0.200 absorbance units was determined and considered to be the reaction onset time. The amount 
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of endotoxin present is inversely proportional to the reaction time.  The concentration of endotoxin 
in the sample extracts (EU/mL) was determined from the standard curve using Gen5 software 
(BioTek, Winooski, VT, USA). 
Endotoxin load (EU/µg) was calculated by multiplying the EU/mL from the assay by the 
extraction volume and dividing by the quantity of dust on the half filter. 
Endotoxin concentration (EU/m3) was calculated as follows:  
               [(E * D * EV) - EB] * 103 / V……………………………………………… (3.2) 
E is concentration of endotoxin in the sample extracts (EU/ml) 
D is dilution factor 
EV is extraction volume 
EB is endotoxin units per milliliter from the blank sample 
V is the volume of air sampled (m3) 
 
Endotoxin concentrations (EU/m3) and endotoxin loads (EU/µg) were reported as a function 
of particulate size fraction (PM2.5 and PM10).  The content is expressed in terms of endotoxin unit 
per microgram of dust (EU/µg) and endotoxin unit per cubic meter (EU/m3) of sampled air for 
each of the PM2.5 and PM10 size fractions. 
3.3 Population 
3.3.1 Population recruitment and training 
The population study targeted adult residents of Estevan and Swift Current who were 50 
years and older.  Estevan has a total population of 11,054 (census 2011) while Swift Current has a 
population of 15,503 (census 2011).  The three phases of data collection included: Phase 1 from 
April-June 2013, Phase 2 from October-December 2013 and Phase 3 from April-June 2014.  
Season of testing was classified as fall (October, November and early December) and spring 
(April, May and early June).  The phased approach was utilized to account for potential variations 
by time of year (season).  During each Phase, adults 50 years and older were recruited in both 
communities.  Older adults were chosen for the study as effects from airborne exposures are likely 
to be more prevalent in an older population.  Recruitment was conducted through advertisements 
in the community as well as from a calling list made available by the Lung Association of 
Saskatchewan.  Eligibility of participants was confirmed through a screening questionnaire.  
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Ineligibility included nursing home residence, being absent from the city for more than one week 
during the study period, and any health issue that impeded the ability to undertake pulmonary 
testing.  Eligible participants were invited by mail and telephone to attend a study orientation and 
pre-assessment.  The recruitment and selection were identical in each phase of the study.  The 
participants could be recruited in any phase and once recruited, the participant could continue in 
only one or in all phases.  
Participants’ pre-assessment and orientation were carried out by a member of the research 
team and research nurses from the study communities.  The orientation included: signing the 
consent form; instructions on how to complete a diary of daily symptoms; instruction and practice 
in how to use and report on peak expiratory flow monitoring.  Pre-assessment included a breathing 
test (spirometry), blood pressure, weight, height, waist circumference, and completion of a 
baseline questionnaire (Appendix B). 
3.3.2 Daily diary of exposures, symptoms, and FEV1 
During each study phase subject specific respiratory data were collected using MY 
Respiratory Health DAILY DIARY (Figure 3-3).  This was an easy to fill one-page per day diary. 
The contents of the daily diary (Appendix C) completed by each participant were based on 
questions from a standardized questionnaire American Thoracic Society Respiratory Disease 
Questionnaire [3] which was used in previous studies in Saskatchewan [1, 4]. 
 
 
 
 
 
 
Figure 3-3. Daily Diary and Piko-1 for FEV1 monitoring. 
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Participants completed the information in the diary twice a day, morning and evening, for 
the duration of each study phase.  The diary collected information on exposures, symptoms and 
peak expiratory flow measures.  Information on time spent outdoors and exposure to smoke as 
well as information on levels of symptoms (cough, phlegm, and wheeze), degree of symptom 
disturbance were recorded twice a day.  Forced expired volume in one second (FEV1) recordings 
(5 best measures of a maximum of 7 measures) were recorded at the same time as symptom 
reporting.  FEV1 was measured using the PIKO-1 meter. The PIKO-1 is a small and portable 
electronic peak flow/FEV1 meter device (Ferraris, Pulmonary Data services, INC, Louisville, CO, 
USA) (Figure 3-3).  The FEV1 was performed as an exhaled maneuver and the testing procedures 
were conducted according to the American Thoracic Society guidelines.  The daily diary contained 
a detailed reminder guide for undertaking the procedure (Appendix D).  FEV1 measures were 
conducted in the morning and evening with the five best blows each morning and each evening 
recorded (litres) in the daily diary for the duration of each study phase.   
To align the pulmonary measures to the weekly environmental values, weekly mean, 
minimum and maximum FEV1 values were calculated.  For each participant the highest daily FEV1 
recorded for morning and evening were used in the calculation of weekly pulmonary measures. 
Weekly mean FEV1 (meanFEV1) was determined by calculating a mean from the highest daily 
FEV1 for each day of the week.  Weekly minimum (minFEV1) was the lowest overall FEV1 for 
the week from the daily measures.  Weekly maximum (maxFEV1) was the highest overall FEV1 
for the week from the daily measures.  Phase (mean, min, max) were determined by calculating 
the mean of the weekly values (meanFEV1, minFEV1, maxFEV1) for each Phase and each 
community. 
3.4 Variables of Study for the Thesis 
3.4.1 Study variables 
In this thesis, secondary data of self-measured lung function obtained from the adult study 
population in Estevan and Swift Current were used.  The study also used endotoxin level data 
measured in particulate samples collected from the study communities.  Finally, endotoxin content 
of PM2.5 and PM10 and FEV1 variables were used in the test for association. 
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3.4.1.1 Dependent variable 
The primary outcome of interest for paper 2 was the forced expiratory volume in the first 
second of expiration (FEV1).  The respiratory health daily diary was used to twice daily record the 
FEV1 measurements. 
3.4.1.2 Independent variables 
The primary exposure of interest in this thesis was endotoxin content present in particulate 
matter (PM) sizes 2.5 and 10 obtained from Estevan and Swift Current during each of the Phases.  
3.5 Data analysis 
Data analyses were carried out using the Statistical Package for the Social Sciences (SPSS) 
version 22 (IBM, Armonk, NY, USA).  Statistical significance was set at p < 0.05 based on two-
sided calculations.  Specific analysis is described in detail in the two manuscript chapters (Chapters 
4 and 5). 
As an overview, prior to statistical analysis, endotoxin levels in particulate matter were log-
transformed to normalize the variables.  Geometric means and geometric standard deviations of 
dust (µg/m3) were calculated.  The analysis was undertaken for the endotoxin contents (EU/µg and 
EU/m3) by particulate size (PM2.5 and PM10) in each phase and in each community.  Mann-Whitney 
test was used to compare endotoxin in PM2.5 and PM10 in each phase and in combined phases 
(Phases 1-3 combined) for each community.  The Mann-Whitney test was applied to this data 
because of the small sample size, the ordinal nature of the data, and the independency of variables.  
The median differences were calculated between PM2.5 from Estevan and PM2.5 from Swift 
Current, likewise in PM10, from Estevan and PM10 from Swift Current using Mann-Whitney test.  
Statistical significance of the median differences is reported. 
For the population samples, descriptive analyses were performed for the continuous 
variables age and height.  The association between meanFEV1, minFEV1, and maxFEV1 variables 
and endotoxin levels (EU/mg and EU/m3) were tested using generalizing estimating equations to 
account for repeated measurements.  Based on the previous studies, the confounders included in 
the analysis were gender, age, height and smoking status. 
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3.6 Ethical approval 
The University of Saskatchewan Research Ethics Board approved this study (BIO 11-172). 
The principal investigators and the research team of the project “The impact of airborne 
environmental contaminants on respiratory public health in Saskatchewan” (Drs. J. Gordon and D. 
Cockcroft and the ARG research team) approved the use of population study as secondary data for 
analysis in this thesis and the particulate samples for endotoxin analysis. 
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4.1 Contribution of Paper 1 to the thesis 
The work presented in this chapter describes analysis of endotoxin in particulate matter [PM] of 
size 2.5 and 10 µm from samples collected in Estevan and Swift Current, Saskatchewan. The 
analysis was done in phases based on the periods of PM collection. The Airways Research Group 
designed the work, collected the samples and undertook the gravimetric analysis. I set up the 
research questions specific to this study.  I initiated and completed the endotoxin analysis under 
their supervision. I completed all the experimental work including extraction, sample 
preparation, and subsequent endotoxin analysis. This paper answered the first and second 
research questions and likewise addressed the hypotheses:  
1.  What is the concentration (EU/m3) and load (EU/µg) of endotoxin in particulate matter (PM2.5 
and PM10) in the communities of Estevan and Swift Current? 
2. What is the variation in ambient endotoxin distribution in particulate matter (PM2.5) and 
(PM10) and does this differ between Estevan and Swift Current? 
Hypothesis 2-1: There are differences in endotoxin levels (concentration and load) in PM2.5 
compared to PM10 within each community and each phase. 
 
Hypothesis 2-2: There are differences in endotoxin levels (concentration and load) in PM2.5 
and PM10 between each community and each phase. 
 
In all experimental stages, technical assistant was provided by Brooke Thompson. As 
first author, I wrote all the draft version of the manuscript and incorporated revision advised by 
my supervisor, co-supervisor, and the Airways Research Group (ARG) team. This work was 
fully supervised by Drs. Katselis and Kirychuk. 
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4.2 Abstract 
Globally, particulate matter of various sizes in the air has become an environmental concern. 
Assessing ambient particulate matter and analysis of its organic composition is not widely studied 
compared to indoor air.  Endotoxin, a component of the gram-negative bacteria cell wall, binds to 
particulate matter, and triggers airway inflammation when inhaled.  This study compared 
endotoxin levels in particulate matter of 2.5 and 10 µm size fractions in two rural communities, 
Estevan and Swift Current, in southern Saskatchewan, Canada.  
Samples were collected in seven-day increments for three eight-week phases in the two 
communities.  Endotoxin concentrations (EU/m3) and loads (EU/µg) were reported as a function 
of particulate size fraction (PM2.5 and PM10).  
The highest levels of endotoxin (EU/µg) found in Estevan were 0.02 (Phase 1), 0.03 (Phase 
2) and 0.01(Phase 3), while endotoxin (EU/m3) were 0.04 (Phase 1), 0.07 (Phase 2) and 0.02 (Phase 
3).  Similar trends were found in Swift Current with 0.04 (Phase 1), 0.10 (Phase 2), and 0.05 (Phase 
3) in endotoxin (EU/µg), while 0.07 (Phase 1),0.13 (Phase 2),and 0.08 (Phase 3) were found in 
endotoxin (EU/m3).   
In Estevan there were no significant differences between PM2.5 and PM10 for endotoxin load 
in any of the phases (p > 0.05), but there were significant differences in endotoxin concentrations 
in all the phases (p < 0.05).  In Swift Current, endotoxin loads were significantly different between 
PM2.5 and PM10 in Phases 2 and 3 only, while endotoxin concentrations were statistically 
significant for all phases (p<0.05).  
Comparing the same particulate size in Estevan and Swift Current, endotoxin loads for PM2.5 
were significantly higher in Swift Current as compared to Estevan (p≤ 0.05), while differences in 
PM10 endotoxin loads were only seen in Phases 2 and 3.  In regards to endotoxin concentration, a 
statistically significant difference was only found in phase 3 (p<0.05) with higher concentrations 
in Swift Current as compared to Estevan for both PM2.5 and PM10.  In general, endotoxin 
concentrations were higher in PM2.5 as compared to PM10 and varied by season and community.  
 
Keywords: Ambient endotoxin; Particulate matter; LAL assay; Outdoor air quality; Rural 
communities 
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4.3 Introduction  
Air pollution is a key problem in both emerging and developed countries giving rise to 
environmental and health concerns.  Most industrialized cities suffer from severe atmospheric air 
pollution due to inappropriate control of discharges emanating from industries [1].  Industrial 
development induces pollutants which include particulate matter (PM), sulphur dioxide (SO2), and 
nitrogen dioxide (NO2).  Particulate matter is a complex mixture of solid and liquid particles in the 
air [2].  Ambient PM with 50% cut-off of particles of aerodynamic size less than 2.5 um (PM2.5) 
and 10 µm (PM10) has been shown to have both acute and chronic effects on human health [2-4]. 
Particulate matter can adsorb other air contaminants such as ammonia and endotoxin [5]. 
Therefore, the composition of particulate matter, including the assessment of endotoxin on PM, is 
important in the evaluation of respiratory health risks to the exposure [6].  Endotoxin as a 
biological agent is embedded in the cell wall of both pathogenic and saprophytic gram-negative 
bacteria [7].  It consists of lipopolysaccharide (LPS), whose molecules are made up of Lipid A, 
polysaccharide nucleus, and polysaccharide chains.  Lipid A is similar in all species of bacteria 
and is responsible for the toxic effects of endotoxin [8, 9]. 
 Endotoxin is ubiquitous, and is found in homes, at workplaces, and in both rural and urban 
environments [10].  Sources of endotoxin at home include kitchen compost bins, humidifiers, and 
pets [11].  In rural environments, significant sources include animal confinement facilities, grain 
storage facilities, and crop harvesting [12, 13].  A 2010 study in California’s central valley found 
the highest concentrations of endotoxin immediately downwind from agricultural activities [14]. 
Of the pollutants studied, which included PM2.5, elemental carbon, and PM10, only PM10 levels 
were found to correlate with endotoxin loads [14].  Similar findings were observed in a study of 
ambient endotoxin in Prince George and Kelowna, British Columbia, Canada where endotoxin 
concentrations were positively associated with agricultural dust of both PM2.5 and PM10 size, but 
the association was stronger with PM10 [15].  Studies performed in other countries have reported 
the same trend of endotoxin bound to particulate matter [10-12].  A study in a German metropolitan 
area [16] reported higher endotoxin levels in PM10, compared to endotoxin in PM2.5.  This 
observation was partly associated with potential sources of endotoxin around the collection sites 
such as trash bins, gardens, sewage and animal facilities areas. 
Endotoxin has dual properties; it can cause inflammation of the respiratory tract in adults 
and children, while it also can modify the immune response, reducing the risk of development of 
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atopic disease in children [17].  The significant role of endotoxin in development of dust-related 
respiratory symptoms in agricultural workers has been well studied but the dose-response 
relationship is yet unclear [18, 19].  Indoor house dust has been widely used to assess the individual 
level of endotoxin exposure in homes [20, 21], but few studies have measured endotoxin levels in 
ambient environmental dusts, especially in Canada [10, 22]. 
A precursor to this study, conducted in 2000 among the children residing in these 
participating communities found high and differing asthma prevalence rates of 21.4% and 16.2% 
[23].  In the associations between indoor domestic endotoxin levels and asthma in children, the 
findings showed that indoor endotoxin was not a major risk factor for current asthma but may 
aggravate the severity of existing asthma [24].  Few studies have evaluated endotoxin levels in 
ambient environmental dusts.  Therefore, this follow-up study described herein explored the 
concentration and load of endotoxin in ambient particulate matter in these communities.  In the 
current study, our aim was to determine levels of ambient endotoxin in particulate matter in PM2.5 
and PM10 in two rural communities with differing industrial composition. 
4.4 Materials and methods 
4.4.1 Sample collection 
Sampling occurred in the communities of Estevan (population 11,054), and Swift Current 
(population 15,503), whose geographical and other relevant characteristics are described in Table 
4-1.  Sampling equipment was co-located with provincial air sampling equipment with the site 
based on the Saskatchewan Air Monitoring Directive [25].  The site was chosen to represent an 
efficient assessment of air quality for the general public in the area taking into account site and 
power accessibility, air dispersion modelling, topographical effects, local interferences and 
security [25].   
The samples were collected in spring 2013 (Phase 1), fall 2013 (Phase 2), and spring 2014 
(Phase 3), which represent the study phases.  Ambient particle samples were collected using a 2-
stage (PM 2.5 and 10) sampler (Dekati, ISO 23210, Dekati Ltd, Tampere, Finland) connected to a 
high-volume pump (Gilian, Aircon2, Sensidyne, FL, USA) that ran at a flow rate of 30 L/minute. 
PM2.5 and PM10 were collected on pre-weighed 25 mm polycarbonate filters (2.0µm, SKC Inc., 
Eighty-four, PA, USA).  Each sample was collected over a seven-day period (sample), and samples 
were collected for the length of each study period (Phase).  One blank field filter was taken for 
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each five filters.  The blank field filter accounted for any endotoxin accumulation from technical 
and field, and storage activities.  Due to technical difficulties, Phase 2 resulted in a smaller sample 
size collection. 
Post sampling, filters were stored in their identity-labelled clear styrene cassettes (SKC, 
Concept Controls, Edmonton, AB, CA), date stamped, and placed in a sealed labelled Ziploc bag 
with desiccation packs, and refrigerated at 4°C until transport and post-weights. 
4.4.2 Gravimetric measurement 
The weight of filters was measured before and after sampling using a MX5 microbalance 
(Mettler Toledo, Mississauga, ON, CA) with a resolution of 0.1 µg.  Before weighing, filters were 
equilibrated to room temperature and humidity for 30 minutes.  The filters were placed through a 
static neutralizer (PRX U Small SET, Haug Static, Richmond Hill, ON, Canada) and weighed in 
triplicate.  The average weight and PM concentration (µg/m3) were calculated for each size 
fraction. 
The PM concentration (µg/m3) in the air volume sampled was calculated as follows:  
                [(W2 – W1)] *103/ V ………………………………………………………. (4.1) 
Where: 
W1 is the mean pre-filter weight (µg) 
W2 is the mean post-sampling weight (µg)  
V is the volume of air sampled 
4.4.3 Filter extraction 
 Filter extractions were carried out after all samples from all phases were collected (i.e. after 
August 2014).  For extraction each filter was cut in half using sterile scalpel blade.  One half of 
the filter was placed back in the storage container and stored in the desiccator at 4oC for other 
analyses.  The second half of the filter was immediately extracted for endotoxin analysis.  This 
half of the filter was placed in a 2 mL bead beating tube containing 2 g of 2 mm Zirconia beads 
(BioSpec, Bartlesville, OK, USA).  One milliliter of 0.05% Tween 20 (Fisher Scientific, Ottawa, 
ON, Canada) in endotoxin-free water (Hyclone, GE Healthcare, Mississauga, Canada) was added 
to each tube and bead beaten for 3 min at the highest setting using the Retsch MM 400 Oscillating 
Mill (Retsch, Newtown, PA, USA).  Tubes were placed in an ice box between bead beating and 
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centrifugation.  The tubes were centrifuged at 13,000 rpm for 5 min (Thermo Scientific Sorvall 
Legend Micro 17 Centrifuge, Fisher Scientific, Ottawa, ON, Canada).  The supernatant was 
transferred to 1.5ml polypropylene tubes (Fisher Scientific, Ottawa, ON, Canada) and centrifuged 
at 13,000 rpm for 10 min at 4oC (Eppendorf Centrifuge 5430R, Eppendorf Canada, Mississauga, 
ON, Canada).  Finally, the supernatant was removed, aliquoted, and stored at -80oC until endotoxin 
analysis. 
4.4.4 Endotoxin analysis 
Endotoxin was determined using the Kinetic chromogenic Limulus Amoebocytes Lysate 
(LAL) assay according to the manufacturer’s recommendations (Lonza, Walkersville, MD, USA).  
One aliquot of supernatant (extract) was thawed at room temperature.  100 µL of each undiluted 
sample extract, a LAL reagent water blank and the endotoxin standards (E.coli 055:B5, five 
standards optimized for the range 0.005 to 50 EU/mL), were dispensed in triplicate into 96-well 
plates.  The plate was then incubated in the ELx808 plate reader (BioTek, Winooski, VT, USA) for 
10 minutes at 37oC.  After incubation, kinetic LAL reagent was added to each well and the plate 
was further incubated for another 2 hours.  Absorbance was monitored at 405 nm and the time 
required for the absorbance to increase to 0.200 absorbance units was determined and considered 
to be the reaction onset time.  The amount of endotoxin present is inversely proportional to the 
reaction time.  The concentration of endotoxin in the sample extracts (EU/ml) was determined 
from the standard curve using Gen5 software (BioTek, Winooski, VT, USA). 
Endotoxin load (EU/µg) was calculated by multiplying the EU/mL by the extraction volume 
and dividing by the quantity of dust on the half filter.  Endotoxin concentration (EU/m3) was 
calculated as follows:  
 
               [(E * D * EV) - EB] * 103 / V……………………………………………… (4.2) 
E is endotoxin units per milliliter 
D is dilution factor 
EV is extraction volume 
EB is endotoxin units in blank sample 
V is the volume sampled 
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4.4.5 Statistical methods 
All statistical analyses were carried out using SPSS version 22 (IBM Statistics, Armonk, 
NY, USA).  Analyses on environmental variables were completed after log transformation, and 
geometric means and geometric standard deviations by phase were used to describe the 
environmental data for both dust and endotoxin.  The Mann-Whitney (M-W) test was used to 
assess significant differences in median endotoxin (EU/µg and EU/m3) between PM2.5 and PM10 
within a community in each phase, and between the communities in the same phases.  In all the 
tests, differences were considered statistically significant at p-value <0.05. 
4.5 Results 
A summary of characteristics of the communities and sample sites are shown in Table 4.1 
The study was comprised of a total of 106 filters; 50 samples (25 PM2.5 and 25 PM10) from Estevan 
and 56 samples (28 PM2.5 and 28 PM10) from Swift Current for the three phases.  
4.5.1 Estevan 
In this community, the dust concentration ranged from 0.34 to 2.72 µg/m3 across the phases. 
There was a significantly greater concentration of PM2.5 than coarse dust (PM10) for all 3 phases 
(Table 4.2).  
As shown in Table 4.3, the highest levels of endotoxin load (geometric mean in EU/µg) 
found in Estevan were 0.02 (Phase 1), 0.03 (Phase 2) and 0.01 (Phase 3).  In all phases, there were 
no statistically significant differences in endotoxin load between the particle size fractions. 
Endotoxin concentration (geometric mean in EU/m3) levels were 0.04 (Phase 1), 0.07 (Phase 2) 
and 0.02 (Phase 3) as shown in Table 4.4.  For Estevan, there was significantly greater endotoxin 
concentration in PM2.5 compared to PM10 for all phases. 
4.5.2 Swift Current 
As shown in Table 4.2, in this community, dust concentration ranged from 0.20 to 1.92 µg/m3 
across the phases.  The dust concentration was significantly greater in the PM2.5 size fraction as 
compared to that of the PM10 for all phases in Swift Current. 
Highest levels of endotoxin load (geometric mean in EU/µg) found in Swift Current were 
0.04 (Phase 1), 0.10 (Phase 2), and 0.05 (Phase 3) (Table 4.3).  Endotoxin load was significantly 
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higher in the PM2.5 size fraction as compared to the PM10 in Phases 2 and 3 for Swift Current.  
For Swift Current, 0.07 (Phase 1), 0.13 (Phase 2), and 0.08 (Phase 3) were found in endotoxin 
concentration (geometric mean in EU/m3) as shown inTable 4.4.  There was significantly greater 
endotoxin concentration in the PM2.5 size fraction as compared to PM10 (Table 4.4) for all Phases. 
4.5.3 Endotoxin comparisons between communities and by size fraction 
The comparison between Estevan and Swift Current communities for endotoxin load 
(EU/µg), by phase and size fraction, is described in Figure 4.1 (A-C) and Figure 4.2 (A-C).  Swift 
Current had almost three times the endotoxin load as Estevan in Phase 2.  Endotoxin load was 
significantly higher in the PM2.5 size fraction as compared to the PM10 in Phases 2 and 3 for Swift 
Current.  In comparison, Estevan had no significant differences in endotoxin load between size 
fractions for any of the phases.  There was significantly greater endotoxin load in the PM2.5 size 
fraction in all phases for Swift Current as compared to Estevan.  This trend held for PM10 for 
Phases 2 and 3, where there were significantly higher levels in Swift Current as compared to 
Estevan. 
Comparison of the mean endotoxin concentration (EU/m3) by phase and by size fraction 
between the two communities is described in Figure 4.3 (A-C) and Figure 4.4 (A-C).  The mean 
PM2.5 endotoxin concentration was greater in Swift Current as compared to Estevan in all phases, 
but this difference was significant only in Phase 3 (p<0.0001).  For PM10, the endotoxin 
concentration was more variable between communities and by community.  Only in Phase 3 were 
the endotoxin concentrations significantly different between communities with Swift Current 
having a higher level (p<0.02).  There was significantly greater endotoxin concentration in the 
PM2.5 size fraction as compared to PM10 (Table 4-4) for all Phases for both communities. 
4.6 Discussion 
The purpose of this study was to assess endotoxin distribution by particulate size fraction in 
two communities with different regional industries.  In this study, there were significant 
differences in the endotoxin concentration between the two size fractions.  PM2.5 consistently had 
greater endotoxin concentration as compared to the PM10 size fraction.  In general, the study 
findings have revealed that endotoxin is present in both PM2.5 and PM10.  The findings in our study 
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agree with our hypothesis that more endotoxin are bound to smaller particulate size diameter as 
compared to coarse particulate.  In our study, endotoxin was about 10-fold higher bound to PM2.5 
as compared to PM10.  Most previous studies of ambient endotoxin levels reported higher levels 
of endotoxin bound to PM10 compared to PM2.5 [15, 16].  Any attached pollutants at PM2.5 will 
have the tendency to penetrate to the inner regions of respiratory tract [3].  The higher endotoxin 
levels found at PM2.5 in the current study could be a reflection of the predominant industry in these 
communities, which is agriculture, a known source for high levels of endotoxin. 
Endotoxin is recognized as an important component of particulate matter associated with 
occurrence and exacerbation of airway disease [26].  The endotoxin concentrations in this study 
are many fold lower than 50 EU/m3, which is the occupational exposure limit recommended by 
the Dutch Expert Committee on Occupational Safety and Health [27,28].  There are no 
recommendations for ambient endotoxin exposure levels. 
Overall, our measurements showed that the mean endotoxin level found in Swift Current, 
primarily an agricultural environment, were significantly higher compared to Estevan, both an 
industrial, with open coal mining, and an agricultural community.  Our results confirm outcomes 
from previous studies showing that agricultural environments experience higher levels of 
endotoxin as compared to other environments.  Endotoxin primarily originates from gram-negative 
bacteria that are predominant in animal confinement areas, crops, and storage facilities [12,17]. 
For instance, an outdoor ambient endotoxin study carried out in Prince George and Kelowna, BC, 
Canada between 2005 and 2006 found a positive association between agricultural dust factors in 
particulate sizes and the level of endotoxin [17].  It is possible that coal mining activities in Estevan 
could have an impact on the measured endotoxin levels; Sebastian and his co-workers reported 
that heated particulate matter generated from industry can inactivate endotoxins, such that they 
possess reduced activities in LAL assays [29]. 
Endotoxin concentrations in our studies were lower compared to previous studies, for 
instance, the study in Regina, Saskatchewan, Canada [30].  This is likely due to the differences in 
the ambient air pollution sources.  Regina (216,528), is one of the largest urban centers in 
Saskatchewan with a significantly larger population size and industrial and vehicular contributions 
to air quality as compared to the much smaller centers studied herein.  Our endotoxin in PM2.5 is 
similar to that found by others, however the endotoxin in PM10 is lower than the levels found in 
other similar studies, as can be seen in Table 4-5.  In comparison to other studies our study had 
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significantly greater collection volumes per filter.  Samples were collected at a greater flow rate 
for much longer sampling periods than comparative studies.  These greater volumes, particularly 
for the low ambient levels we were sampling, provided an adequate sample for the analyses that 
were undertaken giving strength to the results.  
In the current study the highest levels of endotoxin were found in the fall (Phase 2).  This is 
similar to a study from British Columbia that found the highest levels of endotoxin in summer and 
fall with lowest levels in winter and spring [17].  In the communities we studied, farming activity 
is at its peak during fall seasons as farmers can be busy with harvesting, hauling bales, putting 
machinery away, moving cattle and applying fertilizer.  It is possible that farming activities might 
be a contributing factor to elevated endotoxin loads for Swift Current, although higher endotoxin 
levels may also be due to components derived from plant materials and deposits on leaves surfaces 
[31].  Based on the previous assumption, Carty et al. studied the ambient endotoxin levels in PM2.5 
and effects of seasonal variation on endotoxin levels in Germany [32].  The findings showed that 
predominantly high levels of endotoxin in spring and summer compared to the cold season could 
be possible due to plants growth during these periods.  Furthermore, a study of airborne endotoxin 
in different background environments and seasons has shown that endotoxin concentration levels 
were higher in spring compared to winter, but peaked in October [22], while a study in Beijing 
China has reported that endotoxin concentration was higher in both spring and winter [33].  The 
observed difference between our study and this last study might be due to various contributors to 
endotoxin levels including different forms of agricultural practice or climatic variations.  However, 
it is worth mentioning that several studies reported for occupational settings were inconsistent with 
respect to the seasonal variation of endotoxin [34-36]. 
Previous studies emphasized several confounders in this type of study which are not different 
from ours.  Differences in climatic conditions, industrial climate, and inter-laboratory procedure 
are the main confounders.  One study indicated that season, sampling sites, and weather conditions 
were responsible for 24% of the variability in endotoxin concentration [37].  Another study 
reported on the influence of temperature on the levels of endotoxin [32] while another study also 
reported highest endotoxin levels during warm weather and moderate humidity [17].  These 
observations imply that gram-negative bacteria grow better with certain weather conditions or 
undergo lysis at higher temperature to liberate endotoxin in the air.  A strength of this study is that 
the measurements occurred at the same time periods in both communities, reducing the error 
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associated with seasonal differences.  However, the limited number of collection samples and the 
low quantity of dust collected may influence the study findings. 
4.7 Conclusions 
Our study shows that endotoxin in Estevan and Swift Current communities is predominant 
in the PM2.5 size fraction as compared to PM10.  The finding is important as smaller size fractions 
have the potential for greater influences on lower respiratory health.  Endotoxin, and in particular 
endotoxin load, was higher in Swift Current as compared to Estevan.  The major industrial 
activities in these communities may have a strong influence on the endotoxin levels. 
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Table 4-1. Summary of sample locations and data collections. 
Study parameter Sample sites 
 
 
 
Estevan Swift Current 
Sampling periods 
 
Phase 1 
 
Phase 2 
 
Phase 3 
 
 
 
Spring 2013 
 
Fall 2013 
 
Spring 2014 
 
 
Spring 2013 
 
Fall 2013 
 
Spring 2014 
Sampling location Rural community, industrial-active 
open coal mining, oil and gas 
production, power generation, 
agricultural production 
Rural community, primarily 
agricultural production-cereal and 
other specialty crops, livestock 
Population density /km2 
 
586.6 644.9 
Number of samples 
 
Phase 1 
 
Phase 2 
 
Phase 3 
 
 
 
10/10 (PM2.5/PM10) 
 
5/5 (PM2.5/PM10) 
 
10/10 (PM2.5/PM10) 
 
 
10/10 (PM2.5/PM10) 
 
8/8 (PM2.5/PM10) 
 
10/10 (PM2.5/PM10) 
Mean sample volume (m3) 
 
Phase 1 
 
Phase 2 
 
Phase 3 
 
 
 
302 
 
290 
 
305 
 
 
306 
 
293 
 
305 
Phase 1 (April-June 2013); Phase 2 (October-December 2013); Phase 3 (April-June 2014); PM2.5 particulate matter size fraction 
2.5; PM10 particulate matter size fraction 10. 
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Table 4-2. PM2.5 and PM10 Concentration (µg/m
3) by phase and community. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Phase 1 (April-June 2013); Phase 2 (October-December 2013); Phase 3 (April-June 2014); Combined Phases (Phases 1-3 combined); n number of samples;  
 min minimum; max maximum; GM geometric mean; GSD geometric standard deviation; significance P-value <0.05. 
 
 
 
 
Variable                            Estevan                       Swift Current 
                                                                                                                                          
n        GM (GSD)        Min-Max        P-value n        GM (GSD)       Min-Max      P-value 
Phase 1 
PM2.5 
PM10 
 
10       2.52 (2.34)        0.29-4.81           0.001 
10       0.34 (1.81)        0.17-1.22         
 
10       1.92 (1.50)       1.23-4.59       <0.001 
10       0.23 (1.57)       0.09-0.44        
 
Phase 2 
PM2.5 
PM10 
 
 
5          2.72 (1.58)       1.54-5.09           0.009 
5          0.59 (1.42)       0.42-0.95         
 
 
8         1.34 (1.85)       0.64-4.60          0.001 
8         0.20 (5.33)       0.00-0.52        
 
Phase 3 
PM2.5 
PM10 
 
 
10        2.09(1.95)       0.44-4.77          <0.001 
10        0.36(1.45)       0.15-0.51         
 
 
10       1.61 (1.43)      1.10-3.55          0.001 
10       0.44 (1.59)      0.27-1.47        
 
Combined Phases 
PM2.5 
PM10 
 
 
25       2.38 (2.01)      0.29-5.09            <0.001 
25       0.39 (1.65)      0.15-1.22         
 
 
28      1.63 (1.59)      0.64-4.60           <0.001 
28      0.28 (2.70)      0.00-1.47       
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 Table 4-3. PM2.5 and PM10 endotoxin load (EU/µg) by phase and community. 
 
 
 
 
 
 
 
 
 
 
 
 
Phase 1 (April-June 2013); Phase 2 (October-December 2013); Phase 3 (April-June 2014); Combined Phases (Phases 1-3 combined); min minimum; max maximum; GM 
geometric mean; GSD geometric standard deviation; significance P-value <0.05; EU/µg Endotoxin unit in 1 µg of dust. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variable                             Estevan                    Swift Current 
  
       GM (GSD)        Min-Max     Median         P-value 
 
GM (GSD)         Min-Max     Median       P-value 
Phase 1 
PM2.5 
PM10 
 
      0.02 (1.61)          0.01-0.04      0.02               0.88 
      0.02 (6.10)      0.0014-1.24      0.009 
 
0.04 (3.60)         0.01-0.52     0.038             0.11 
0.02 (2.86)         0.00-0.05     0.012 
 
Phase 2 
PM2.5 
PM10 
 
 
      0.03 (2.09)          0.01-0.05      0.03              0.18 
      0.01 (4.26)          0.001-0.03    0.009          
 
  
0.10 (2.43)        0.04-0.61      0.062             0.03 
0.03 (2.99)        0.01-0.33      0.023 
 
Phase 3 
PM2.5 
PM10 
 
 
      0.01 (1.97)          0.003-0.025  0.008            0.15 
      0.01 (2.15)          0.00-0.01      0.005 
 
 
0.05 (1.51)        0.22-0.89      0.046             0.003 
0.02 (3.68)        0.005-0.45    0.013 
 
Combined Phases 
PM2.5 
PM10 
 
 
      0.01 (2.15)          0.00-0.05     0.013             0.25 
      0.01 (4.44)          0.01-1.24     0.009  
 
 
0.05 (2.68)        0.01-0.61       0.05              0.001 
0.02 (3.23)        0.00-0.45       0.01 
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                    Table 4-4. PM2.5 and PM10 endotoxin concentration (EU/m
3) by phase and community. 
 
 
 
 
 
 
 
 
 
 
Phase 1 (April-June 2013); Phase 2 (October-December 2013); Phase 3 (April-June 2014); Combined Phases (Phases 1-3 combined); min minimum; max maximum; 
GM geometric mean; GSD geometric standard deviation; significance P-value <0.05; EU/m3 endotoxin unit in cubic meters. 
 
 
Variable                        Estevan                 Swift Current 
  
       GM (GSD)     Min-Max      Median        P-value 
 
   GM (GSD)       Min-Max   Median   P-value 
Phase 1 
PM2.5 
PM10 
 
     0.04 (1.94)        0.01-0.08           0.06                  0.01 
     0.01 (7.75)        0.0002-0.33       0.003 
 
   0.07 (3.66)        0.01-1.16      0.05             <0.001 
 0.003 (3.34)        0.00-0.02      0.004 
 
Phase 2 
PM2.5 
PM10 
 
 
     0.07 (2.53)          0.02-0.18         0.07                  0.02 
     0.004 (5.38)        0.0003-0.033   0.005 
 
 
  0.13 (2.18)         0.07-0.77     0.10                0.002 
  0.01 (4.79)         0.00-0.10     0.01  
 
Phase 3 
PM2.5 
PM10 
 
 
     0.02 (1.58)          0.01-0.03        0.013                <0.001 
     0.002 (2.69)        0.0005-0.006  0.002 
 
 
   0.08 (0.58)       0.03-0.18      0.07                 0.002 
   0.01 (3.84)       0.002-0.17    0.01   
 
Combined phases 
PM2.5 
PM10 
 
 
       0.03 (2.36)       0.01-0.18         0.027                <0.001 
      0.003 (5.32)      0.00-0.33         0.003      
 
 
   0.09 (2.57)       0.01-1.16      0.08                <0.001 
   0.01 (3.95)       0.00-0.17      0.007 
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Table 4-5. Comparison of ambient endotoxin measured in studies reported in literature. 
Author Sampling location Sampling period Particulate size Findings in EU/m3 
Allen et al., [15] Urban-Prince George; 
pulp mills, saw mills, 
refinery and other 
industrial plants  
 
Urban – Kelowna; 
agricultural area that 
produce fruit & vegetable 
crop 
Oct. 2005- Sept. 2006 PM2.5 
PM10 
 
 
 
PM2.5 
PM10 
0.15 
0.40 
 
 
 
0.16 
0.67 
     
 
Heinrich et al., [10] 
 
Small towns; livestock -
pigs, sheep, cows, lay 
hens and broilers 
 
Jan-June 2002 
 
PM2.5 
 
PM10 
 
 
1st City 0.006 ; 2nd City 
0.008 
1st City 0.063; 2nd City 
0.071 
 
Morgenstern et al., [16] 
 
Urban; no large scale 
agricultural or potential 
(what can be called) 
industry in the study areas 
 
Mar. 1999-July 2000 
 
PM2.5 
PM10 
 
 
0.019 
0.081 
 
Nilsson et al., [38] 
 
Urban; both traffic sites 
and non-traffic sites 
 
May -Sept. 2009 
 
PM2.5 
PM10 
 
 
0.015 
0.05 
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Figure 4-1 A): Comparison of mean endotoxin load [InEU/g] in PM2.5, Phase 1, between Estevan 
and Swift Current. P-value =0.05 using Mann-Whitney test. Y-axis represents mean log of 
endotoxin concentration and 95% confidential interval; X-axis represents study communities. 
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Figure 4-1 B): Comparison of mean endotoxin load [InEU/g] in PM2.5, Phase 2, between Estevan 
and Swift Current. P-value =0.01 using Mann-Whitney test. Y-axis represents mean log of 
endotoxin concentration and 95% confidential interval; X-axis represents study communities. 
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Figure 4-1 C): Comparison of mean endotoxin load [InEU/g] in PM2.5, Phase 3, between Estevan 
and Swift Current. P-value <0.001 using Mann-Whitney test. Y-axis represents mean log of 
endotoxin concentration and 95% confidential interval; X-axis represents study communities. 
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Figure 4-2 A): Comparison of mean endotoxin load [InEU/g] in PM10, Phase 1, between 
Estevan and Swift Current. P-value >0.05 using Mann-Whitney test. Y-axis represents mean log 
of endotoxin concentration and 95% confidential interval; X-axis represents study communities. 
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Figure 4-2 B): Comparison of mean endotoxin load [InEU/g] in PM10, Phase 2, between 
Estevan and Swift Current. P-value = 0.03 using Mann-Whitney test. Y-axis represents mean log 
of endotoxin concentration and 95% confidential interval; X-axis represents study communities. 
 
  
L
o
g
 m
ea
n
 e
n
d
o
to
x
in
 l
o
a
d
 (
ln
E
U
/
g
) 
a
n
d
 9
5
%
 C
I 
   
  82  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-2 C): Comparison of mean endotoxin load [InEU/g] in PM10, Phase 3, between 
Estevan and Swift Current. P-value = 0.02 using Mann-Whitney test. Y-axis represents mean log 
of endotoxin concentration and 95% confidential interval; X-axis represents study communities 
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Figure 4-3 A): Comparison of log mean endotoxin concentration [lnEU/m3] in PM2.5, Phase 1, 
between Estevan and Swift Current. P-value >0.05 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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Figure 4-3 B): Comparison of log mean endotoxin concentration [lnEU/m3] in PM2.5, Phase 2, 
between Estevan and Swift Current. P-value >0.05 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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Figure 4-3 C): Comparison of log mean endotoxin concentration [InEU/m3] in PM2.5, Phase 3, 
between Estevan and Swift Current. P-value <0.001 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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Figure 4-4 A): Comparison of log mean endotoxin concentration [InEU/m3] in PM10, Phase 1, 
between Estevan and Swift Current. P-value >0.05 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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Figure 4-4 B): Comparison of log mean endotoxin concentration [InEU/m3] in PM10, Phase 2, 
between Estevan and Swift Current. P-value >0.05 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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Figure 4-4 C): Comparison of log mean endotoxin concentration [InEU/m3] in PM10, Phase 3, 
between Estevan and Swift Current. P-value <0.02 using Mann-Whitney test. Y-axis represents 
mean log of endotoxin concentration and 95% confidential interval; X-axis represents study 
communities. 
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5.1 Contribution of Paper 2 to the thesis 
The work presented in this chapter describes the association between endotoxin levels 
(load and concentration) and forced expiratory volume in 1 second (FEV1) among the adult 
residents in Estevan and Swift Current. Endotoxin data from the first manuscript was used in the 
test for association with secondary FEV1 data using generalizing estimating equations under the 
supervision of Dr. Joshua Lawson. I completed the endotoxin analysis and generated data, while 
FEV1 data was obtained by the ARG research team. Dr. George Katselis and Dr. Shelley 
Kirychuk also checked the produced data and its quality. I set up the research question specific to 
this study. This paper answered my third research question and the hypothesis.  
 
3. What is the association between ambient endotoxin levels (concentration and load) and the 
forced expiratory volume in 1 second (FEV1)? 
 
I wrote the draft version of the manuscript and incorporated the version advised by all 
authors. This work was supervised by Drs. Kirychuk, Lawson, and Katselis. 
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5.2 Abstract 
Exposure to endotoxin, a major biological component of particulate matter, has been found 
to be associated with wheeze, cough, phlegm, and decline in lung function. Indoor endotoxin at 
the household and occupational exposure level has been commonly studied while ambient 
endotoxin has rarely been examined in relation to lung function. 
This study aimed to assess the association between ambient endotoxin level and lung 
function among adult residents in two Saskatchewan communities, Estevan and Swift Current. 
Adult participants were selected from the general population with a screening questionnaire. 
During the three phases beginning in April 2013, Forced Expiratory Volume in 1s (FEV1) was 
recorded in a daily diary, and weekly assessments of endotoxin in a 50% cut-off aerodynamic 
diameter of 2.5 µm and 10 µm of particulate matter were conducted. Associations were examined 
using generalizing estimating equations adjusting for confounders. Interaction of endotoxin and 
smoking was assessed.  
There were 209 adult residents included in the present study. The geometric means of 
endotoxin in dust sampled (EU/µg) and in the sampled air (EU/m3) were less than 0.2 in the two 
communities. However, despite low levels of endotoxin, in Swift Current, mean and max FEV1 
was associated significantly with PM2.5 endotoxin concentration and load in Phase 3. There was 
only significant interaction with smoking for Swift Current in endotoxin concentration PM2.5. 
In this study, there is an inconsistent association between exposure to endotoxin in ambient 
air and the outcome measurements of lung function. Results indicated that low endotoxin levels 
present might not affect the lung function of adults in both communities.  
 
Key words: Adults; Endotoxin; Lung function; Community; Smoking 
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5.3 Introduction 
Respiratory illnesses are one of the most prevalent disease conditions affecting adults [1]. 
According to Health Canada, respiratory problems affect more than 3 million Canadians [2]. In 
the past decade in Canada, respiratory diseases accounted for approximately 10% of all admission 
in the hospital and about 37,000 deaths [2]. Within the same period in Saskatchewan, 8.5% of the 
adult population reported physician-diagnosed asthma [3]. Many studies have established the 
relationship between tobacco smoking and respiratory problems [2]. Short and long term exposure 
to outdoor air pollution has an important influence on the respiratory health of Canadians [4,5]. 
Among 34 countries including Canada, effects of outdoor pollution, on the children’s respiratory 
health cost 1.7 trillion US dollars [6]. Adults are at increased risk from air pollution due to normal 
and pathological aging and other processes [7]. 
Endotoxin, one of the constituents of particulate air pollution has been singled out as the 
most significant biological component associated with the development and exacerbation of 
respiratory diseases in persons exposed to agricultural environments [8]. Endotoxin is regarded as 
a biological agent that can be hazardous to respiratory health [9, 10]. 
Inhalation of endotoxin has a contributing role in respiratory tract obstruction, measured by 
a decrease in forced expiratory volume in 1s (FEV1) [11]. FEV1 is a common spirometric measure 
of lung function that can indicate chronic respiratory problems and systemic inflammation [12].  
In other reviews of the roles of endotoxin in both children and adults’ respiratory problems, 
endotoxin was found to be protective in childhood asthma and responsible for exacerbation of 
asthma in adults [13]. 
According to previous epidemiological studies in the same study locations, in which asthma 
prevalence was higher in Estevan with 21.4 % as compared to Swift Current (16.2%) [14], further 
studies in the children’s population reported a significant association between indoor endotoxin 
load and asthma severity among children [15].  The study described herein further examined these 
communities and the relationships between ambient endotoxin exposure in particulate pollution 
and lung function in older adults in the communities. 
The aim of this study was to determine the associations between endotoxin load (EU/µg), 
endotoxin concentration (EU/m3), and FEV1 in two small urban communities in Saskatchewan, 
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Estevan and Swift Current. Associating lung function with outdoor endotoxin levels has rarely 
been considered in previous studies, and to date, no other study has evaluated the role of ambient 
endotoxin in this region. 
5.4 Materials and methods 
5.4.1 Recruitment and study design 
A study of adults residing in the Estevan and Swift Current communities in Saskatchewan 
was conducted between 2013 and 2014.  Estevan has coal mining, coal-based power generation, 
and agricultural industries with a total population of 11,054 (census 2011).  Swift Current is a 
primarily agriculture-based region with a population of 15,503 (census 2011).  The study involved 
three phases of data collection: April-June 2013, October-December 2013 and April-June 2014.  
Season of testing was classified as fall (October, November and early December) and spring 
(April, May and early June).  A three phased approach was used to account for potential variations 
by time of year (season).  During each Phase, adults 50 years and older were recruited in both 
communities.  Older adults were chosen for the study as effects from airborne exposures would be 
more prevalent in an older population as compared to a younger adult population.  Recruitment 
was by convenience sampling and included response from advertisements and from the Lung 
Association volunteer call list in both communities.  The investigators confirmed eligibility of 
participants through a screening questionnaire.  Ineligibility included nursing home residence, the 
absence of more than one week during the study period, and any health issue that impeded the 
ability to undertake pulmonary testing.  Eligible participants were invited by mail and telephone 
to attend the study orientation and assessment.  The recruitment and selection were similar in each 
phase of the study. 
Participants’ pre-assessment and orientation were carried out by a member of the research 
team and research nurses from the study communities.  At the orientation, the consent form was 
signed and instructions on how to complete a diary of daily symptoms and how to use a peak 
expiratory flow monitoring device (twice a day over the study period) were given.  Pre-assessment 
included a breathing test (spirometry), blood pressure, weight, height, waist circumference, and 
completion of a baseline questionnaire.  Biomedical Research Ethics Board from the University of 
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Saskatchewan, BIO11-172 approved the study.  The participants could be recruited in any phase 
and once recruited, the participant could continue in all phases. 
5.4.2 Exposure assessment 
5.4.2.1 Sample collection 
Sampling occurred in the communities of Estevan (11,054) and Swift Current (15,503).  
Sampling equipment was co-located with provincial air sampling equipment with the site selection 
based on the Saskatchewan Air Monitoring Directive.  The site was chosen to represent an efficient 
assessment of air quality for the general public in the area taking into account site and power 
accessibility, air dispersion modelling, topographical effects, local interferences, and security.  The 
sampling site in Estevan was located in the southeast of the city, on a hill, at the roof of a one story 
building, within a secure compound.  The sampling site in Swift Current was located in the 
northwest of the city, on the rooftop of a one-story provincial building near the highway.   
The samples were collected in spring 2013 (Phase 1), fall 2013 (Phase 2), and spring 2014 
(Phase 3), which represent the study phases.  Ambient particle samples were collected using a 2-
stage (PM 2.5 and 10) sampler (Dekati, ISO 23210, Dekati Ltd, Tampere, Finland) connected to a 
high-volume pump (Gilian, Aircon2, Sensidyne, FL, USA) that ran at a flow rate of 30 L/minute.  
PM2.5 and PM10 were collected on pre-weighed 25 mm polycarbonate filters (2.0µm, SKC Inc., 
Eighty-four, PA, USA).  Each sample was collected over a seven-day period (sample), and samples 
were collected for the length of each study period (Phase).  One blank field filter was taken for 
each five filters.  The blank field filter accounted for any endotoxin accumulation from technical 
and field, and storage activities.  Due to technical difficulties, Phase 2 resulted in a smaller sample 
size collection. 
Post sampling, filters were stored in their identity labelled clear styrene cassettes (SKC, 
Concept Controls, Edmonton, AB, CA), date stamped, placed in a sealed, labelled Ziploc bag 
with desiccation packs, and refrigerated at 4°C until transport and post-weights. 
5.4.3 Gravimetric measurements 
The weight of filters was measured before and after sampling using a MX5 microbalance 
(Mettler Toledo, Mississauga, ON, CA) with a resolution of 0.1 µg.  Before weighing, filters were 
equilibrated to room temperature and humidity for 30 minutes.  The filters were placed through a 
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static neutralizer (PRX U Small SET, Haug Static, Richmond Hill, ON, Canada) and weighed in 
triplicate. The average weight and PM concentration (µg/m3) were calculated for each size fraction. 
The PM concentration (µg/m3) in the air volume sampled was calculated as follows:  
                   [(W2 – W1)] *103/ V ………………………………………………………. (5.1) 
 
Where: 
W1 is the mean pre-filter weight (µg) 
W2 is the mean post-sampling weight (µg)  
V is the volume of air sampled 
 
5.4.4 Filter extraction 
Filter extractions were carried out after all samples from all phases were collected (i.e., from 
June to August 2014).  For extraction, each filter was cut in half using a sterile scalpel blade.  One 
half of the filter was placed back in the storage container and stored in the desiccator at 4oC for 
other analyses.  The second half of the filter was immediately extracted for endotoxin analysis.  
The half filter was placed in a 2 mL bead beating tube containing 2 g of 2 mm Zirconia beads 
(BioSpec, Bartlesville, OK, USA).  One milliliter of 0.05% Tween 20 (Fisher Scientific, Ottawa, 
ON, Canada) in endotoxin-free water (Hyclone, GE Healthcare, Mississauga, Canada) was added 
to each tube and bead beaten for 3 min at the highest setting using the Retsch MM 400 Oscillating 
Mill (Retsch, Newtown, PA, USA).  Tubes were placed in an ice box between bead beating and 
centrifugation.  The tubes were centrifuged at 13,000 rpm for 5 min (Thermo Scientific Sorvall 
Legend Micro 17 Centrifuge, Fisher Scientific, Ottawa, ON, Canada).  The supernatant was 
transferred to 1.5 mL polypropylene tubes (Fisher Scientific, Ottawa, ON, Canada) and centrifuged 
at 13,000 rpm for 10 min at 4oC (Eppendorf Centrifuge 5430R, Eppendorf Canada, Mississauga, 
ON, Canada).  Finally, the supernatant was removed, aliquoted, and stored at -80oC until endotoxin 
analysis. 
5.4.5 Endotoxin analysis 
Endotoxin was determined using the Kinetic chromogenic Limulus Amoebocytes Lysate 
(LAL) assay according to the manufacturer’s recommendations (Lonza, Walkersville, MD, USA).  
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One aliquot of supernatant (extract) was thawed at room temperature.  100 µL of each undiluted 
sample extract, a LAL reagent water blank and the endotoxin standards (E.coli 055:B5, five 
standards optimized for the range 0.005 to 50 EU/mL), were dispensed in triplicate into 96-well 
plates.  The plate was then incubated in the ELx808 plate reader (BioTek, Winooski, VT, USA) for 
10 minutes at 37oC.  After incubation, kinetic LAL reagent was added to each well and the plate 
was further incubated for another 2 hours.  Absorbance was monitored at 405 nm and the time 
required for the absorbance to increase to 0.200 absorbance units was determined and considered 
to be the reaction onset time.  The amount of endotoxin present is inversely proportional to the 
reaction time.  The concentration of endotoxin in the sample extracts was determined from the 
standard curve using Gen5 software (BioTek, Winooski, VT, USA). 
Results for each half filter were calculated as endotoxin units per milliliter (EU/mL).  
Endotoxin load (EU/µg) was calculated by the EU/mL multiplied by extraction volume and 
divided by the quantity of dust on the half filter.  Endotoxin concentration (EU/m3) was calculated 
as follows:  
               [(E * D * EV) - EB] * 103 / V……………………………………………… (5.2) 
E is endotoxin units per milliliter 
D is dilution factor 
EV is extraction volume 
EB is endotoxin units in blank sample 
V is the volume sampled  
                                                         
5.4.6 Lung function assessment 
A daily diary was developed based on a standardized questionnaire [Appendix B; 17] which 
was used in previous studies in Saskatchewan [14,15,18].  The diary includes information such as 
respiratory symptoms, degree of symptoms disturbance, current smoking, and FEV1 recordings.  
The present study analyzed only FEV1 as the outcome.  During the study period, participants 
measured and recorded FEV1 twice daily using a PIKO-1 meter, according to the manufacturer’s 
instruction (Ferraris, Pulmonary Data Services, INC) and in line with American Thoracic Society 
guidelines [19].  Participants were trained during an orientation in the proper FEV1 measuring 
techniques using the PIKO meter. This meter has the ability to reject poor blows or coughs.  
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Written instructions with diagrams were provided to each participant in the daily diary.  Five best 
blows were recorded from at least seven maneuvers in the morning and in the evening before bed.  
FEV1 is regarded as a yard-stick for measuring airflow capacity and reflects the quality of both 
large and small airways [20]. 
5.4.7 Statistical methods 
For the population study, descriptive analyses were performed for categorical variables using 
frequencies and percentages while arithmetic means and standard deviations were used for the 
continuous variables.  The differences between the two communities were tested using the t-test 
analysis.  Data analyses were carried out using the Statistical Package for the Social Sciences 
(SPSS) version 22 (IBM, Armonk, NY, USA).  Statistical significance was set at p < 0.05 based 
on two-sided calculations. 
The outcome of interest, absolute FEV1, was taken in the morning and evening.  The highest 
daily FEV1 recordings in the morning and evening were used for each participant.  To align the 
weekly environmental values to weekly pulmonary measures mean, minimum and maximum 
weekly morning and evening FEV1 values were calculated.  Weekly mean FEV1 (meanFEV1) is 
determined by calculating a mean from the highest daily FEV1 for each day of the week for each 
week of the study.  Weekly minimum (minFEV1) is the lowest FEV1 for the week from the daily 
measures.  Weekly maximum (maxFEV1) is the highest FEV1 for the week from the daily 
measures.  Phase (mean, min, max) were determined by calculating the mean of the weekly values 
for each Phase and each community. 
Prior to statistical analysis, endotoxin contents in particulate matter were log-transformed to 
normalize the variables.  The test for association between meanFEV1, minFEV1, and maxFEV1 
variables and endotoxin were performed using generalizing estimating equations to account for 
repeated measurements.  Based on the previous studies, the potential confounders included in the 
analysis were gender, age, height and smoking status. 
5.5 Results 
A total of 233 adults were screened for the study, with 209 completing at least one or more 
of the three study phases: 105 (50.2%) from Estevan and 104 (49.8%) from Swift Current.  
Characteristics of the populations by study phase are summarized in Table 5-1.  There were no 
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statistically significant differences between adults from Estevan and those from Swift Current for 
age, gender, height and smoking status.  There was a greater percentage of female participants in 
both communities as compared to the general population ratios (Based on 2011 Census, Estevan: 
male – 49%, female – 51%; Swift Current: male – 48%, female – 52%). 
Ambient endotoxin levels by phase and community are shown in Table 5-2.  The endotoxin 
geometric means varied from 0.01 to 0.03 EU/µg and 0.002 to 0.07 EU/m3 in Estevan, while the 
range is from 0.02 to 0.10 EU/µg and 0.003 to 0.13 EU/m3 in Swift Current.  Endotoxin results by 
community were discussed in the first manuscript. 
Similar trends of FEV1 were found in both communities, with higher estimates observed in 
the morning (Table 5-3).  A Phase-specific association between endotoxin and measurements of 
FEV1 are presented in Tables 5-4 to 5-7.  There is no consistent pattern of association in this study.  
In Estevan, the associations between FEV1 and endotoxin were observed in Phase 3 evening and 
Phase 1 morning (EU/m3; PM2.5).  The statistical significance was found only in min FEV1 Phase 
1, while it was borderline (p=0.08) in mean and min FEV1 Phase 3.  Similar association was 
observed in Phase 3 morning mean and max in Swift Current (Table 5-4). 
The association with endotoxin load of PM2.5 was statistically significant only in Phase 3 for 
mean and max FEV1 of both morning and evening (Table 5-6).  In combined phase analysis (Tables 
F1-F4; Appendix F), only mean FEV1 morning in Swift Current was significant for endotoxin 
concentration PM2.5.  Similarly, endotoxin load PM2.5 was significantly associated with max FEV1 
(Table F4).  No overall pattern of association could be established. 
In the analysis for interaction (endotoxin*smoking status) using the combined phases, there 
was a significant interaction for Swift Current between smoking and endotoxin concentration 
EU/m3 in PM2.5.  However, the stratified estimate was considered too unstable due to the small 
sample size (n=7 smokers) and not used (Tables G1-G4; Appendix G). 
5.6 Discussion 
Outdoor air quality is an important contributing factor in the development of respiratory 
illnesses especially in developing and industrial communities [21].  Exposure to endotoxin has 
been associated with changes in lung function at various workplaces, but few studies have explored 
the effects of ambient endotoxin on health and specifically lung function [22].  This study assessed 
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associations between endotoxin, as a component of particulate air pollution, and older adults’ lung 
function in two different small urban communities in Saskatchewan.   
Endotoxins are complex chemical components of the outer membrane of Gram-negative 
bacteria and are released into the air during cell growth and after the occurrence of bacterial death 
[22].  Endotoxin has been known to have health impacts especially when organic dust is inhaled.  
[23].  Studies on inhalation have shown that endotoxin can be associated with a headache, nose 
and throat irritation, nausea, shortness of breath, chest tightness, acute airflow obstruction and 
airway inflammation [24].  In our study, it was hypothesized that endotoxin bound with different 
particulate sizes (PM2.5 and PM10) are associated with lung function measurements from the adult 
residents of two rural communities.  Particulate levels and associated endotoxin levels were 
described in Manuscript one (Chapter 4).  Estevan and Swift Current populations were 
demonstrated to be similar demographically but not with respect to exposure.  Overall, our 
measurements showed that the mean endotoxin level found in Swift Current, primarily an 
agricultural environment, was significantly higher as compared to Estevan, which has both 
industrial activities, with open coal mining activities, and agricultural production.    
In this study of older adults in two rural communities, we found no overall association of 
FEV1 with ambient endotoxin levels.  To the best knowledge of the authors, there is no study in 
which the association of ambient endotoxin and varied FEV1 measurements has been examined.  
The authors did not find an overall association of FEV1 with ambient endotoxin, even though some 
literature suggests that changes in FEV1 are associated with workplace endotoxin [11].  This might 
be due to higher exposure at workplaces than from the ambient air and limits a direct comparison 
of our findings with other studies. 
The present study showed that there was no consistent pattern of associations between FEV1 
and endotoxin in either PM2.5 or PM10.  This is an indirect comparison with a study by Van der 
Zee et al., (2000) that found no consistent associations between air pollution (PM and gases) and 
health indictors (respiratory symptoms and pulmonary function) [25].  It is challenging to find a 
comparable literature report to our study in terms of ambient endotoxin.  Most studies measured 
indoor endotoxin, ambient air pollutants excluding endotoxin, used children in their sample or 
measured Peak Expiratory Force (PEF) instead of FEV1 as the parameter [11, 12, 25-29].   
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The results for Estevan showed no consistent pattern of association between endotoxin and 
FEV1.  When phases were combined, only the endotoxin in PM2.5 was associated with evening 
FEV1.  This pattern of association in Estevan might be due to the study environment.  Estevan is a 
predominantly coal-mining, power generating, and oil and gas producing environment and such 
activities involve heat-producing processes.  Sebastian et al. [30] found that heat has the capacity 
to inactivate the effectiveness of bioactive endotoxin, which might lead to underestimating the 
level of endotoxin observed, and therefore accounted for the observed association found in 
Estevan.  
In Swift Current, FEV1 values in Phase 3 and when phases were combined were significantly 
associated with endotoxin in PM2.5.  However, the observed consistent morning FEV1 decrease as 
endotoxin increased in Swift Current may be explained by the season of data collection, which 
marks the beginning of agricultural practices in this area.  Previous studies have found high 
concentration of endotoxin in a predominantly farming environment [31,32].   
The study of endotoxin and its association with respiratory illnesses in a general population 
has been inconclusive.  In most studies, indoor endotoxin was found to be a contributing factor in 
exacerbation of respiratory illnesses and decline of FEV1 in homes and at workplaces among the  
children and adults [15, 33], while in children populations the findings sometimes are protective 
[34].   
The lack of association in our study could be due to the lower concentrations of endotoxin 
we found compared to concentrations previously reported to cause respiratory tract inflammation.  
Several studies from experimental to epidemiological, with concentrations between 50 and 100 
EU/m3, were reported to influence respiratory tract in human [35-38]. 
One source of differences in the level of endotoxin between our study and previous ones 
might be in location and in the extraction or analysis procedure [39].  The observed pattern of 
association in this study will require further study to better understand if the association is true. 
Another explanation is exposure assessment which was based on a fixed site ambient endotoxin 
concentrations measured at one location in each community.  It could be asked whether exposure 
to air pollution was adequately characterized, if not, the resulting non-differential misclassification 
would probably result in a bias of observed association.  Unlike children, adults spend less time 
outside and therefore the magnitude of misclassification in exposure assessment may be large.  
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While it has been reported that endotoxin maybe protective against the development of respiratory 
illnesses such as asthma, this does not exempt a possible negative impact of endotoxin exposure 
on FEV1 as reported in the present study.  
The use of an unsupervised method of obtaining FEV1 data might result in a lack of 
compliance and possible falsification of results among the adults.  A low number of the participants 
in each phase could be another factor affecting the associations.  To detect endotoxin estimates 
resulting in small changes in lung function, a higher number of adults would be needed to get 
sufficient statistical power.  Furthermore, the poor association may be due to the sugar and fatty 
acid molecular structures of endotoxin present in these environments.  Some other studies found 
that endotoxin with more lactose and hexose units in the sugar chain was more potent to trigger 
biological activities [39-41]. 
One of the strengths of this study was the use of objective measures of endotoxin as well 
objective measures of lung function.  The use of a 7-day monitoring period of dust provided a 
more valid assessment of endotoxin levels.  Further research might be considered to examine the 
use of personal exposure sampling.  
5.7 Conclusions 
The study of the impact of airborne environmental contaminants on respiratory public health 
in Saskatchewan did not show clear effects of endotoxin on FEV1.  The observed pattern of 
association, which may indicate at least a weak effect of outdoor endotoxin, in this study should 
be interpreted with caution.  Adult populations in Estevan and Swift Current are exposed to lower 
concentrations of endotoxin than what is found in other environments, especially in industrial 
areas.  
  
   
102 
 
5.8 References 
1. Makówka, A., Zimmer-Nowicka, J., and Nowicki, M.[Respiratory tract diseases in the 
elderly]. Polskie Archiwum Medycyny Wewnetrznej, 2004. 112: p. 147-160. 
2. Health Canada. Environmental and workplace health. 2013 
http://healthycanadians.gc.ca/diseases-conditions-maladies-affections/disease-
maladie/asthm-eng.php. 10/12/2015 
3. Statistics Canada.Canadian Community Health Survey (CCHS 3.1). CANSIM table 105-
0401- Asthma by age group and sex, household population aged 12 and over,Canada, 
Provinces, Territories, Health regions and Peer groups. 2007. 
4. Abelsohn, A. and Stieb, D.M.Health effects of outdoor air pollution Approach to 
counseling patients using the Air Quality Health Index. Canadian Family Physician, 2011. 
57(8): p. 881-887. 
5. Holguin, F.Traffic, outdoor air pollution, and asthma. Immunology and allergy clinics of 
North America, 2008. 28(3): p. 577-588. 
6. Organization for Economic Co-operation and Development. The cost of air pollution: 
Health impacts of road transport. Paris: OECD Publishing; 2014. 
7. Bentayeb, M., Simoni, M., Baiz, N., Norback, D., Baldacci, S., Maio, S., Viegi, G., Annesi-
Maesano, I., and Group, G.S.I.E.O.H.E.O.a.Q.I.N.H.Adverse respiratory effects of outdoor 
air pollution in the elderly [Review article]. The International Journal of Tuberculosis and 
Lung Disease, 2012. 16(9): p. 1149-1161. 
8. Schwartz, D.A., Thorne, P.S., Yagla, S.J., Burmeister, L.F., Olenchock, S.A., Watt, J.L., 
and Quinn, T.J.The role of endotoxin in grain dust-induced lung disease. Am J Respir Crit 
Care Med, 1995. 152(2): p. 603-8. 
9. Dutkiewicz, J., Cisak, E., Sroka, J., Wójcik-Fatla, A., and Zajac, V.Biological agents as 
occupational hazards-selected issues. Annals of Agricultural and Environmental 
Medicine, 2011. 18(2). 
10. Kirkhorn, S.R. and Garry, V.F.Agricultural lung diseases. Environmental health 
perspectives, 2000. 108(Suppl 4): p. 705. 
11. Cyprowski, M., Sobala, W., Buczynska, A., and Szadkowska-Stanczyk, I.Endotoxin 
exposure and changes in short-term pulmonary function among sewage workers. 
International journal of occupational medicine and environmental health, 2015. 
   
103 
 
12. Sin, D.D., Wu, L., and Man, S.P.The relationship between reduced lung function and 
cardiovascular mortality: a population-based study and a systematic review of the 
literature. CHEST Journal, 2005. 127(6): p. 1952-1959. 
13. Radon, K.The two sides of the “endotoxin coin”. Occupational and environmental 
medicine, 2006. 63(1): p. 73-78. 
14. Rennie, D.C., Lawson, J.A., Cockcroft, D.W., Senthilselvan, A., and Mcduffie, 
H.H.Differences in respiratory symptoms and pulmonary function in children in 2 
Saskatchewan communities. Annals of Allergy, Asthma & Immunology, 2004. 92(1): p. 
52-59. 
15. Rennie, D., Lawson, J., Kirychuk, S., Paterson, C., Willson, P., Senthilselvan, A., and 
Cockcroft, D.Assessment of endotoxin levels in the home and Current asthma and wheeze 
in school‐age children. Indoor air, 2008. 18(6): p. 447-453. 
16. Saskatchewan Ministry of Environment, Air Monitoring Guideline for Saskatchewan, 
Saskatchewan Ministry of Environment, Editor 2012, Ministry of Environment: 
Saskatchewan. p. 46. 
17. Ferris, B.G.Epidemiology Standardization Project (American Thoracic Society). The 
American review of respiratory disease, 1978. 118(6 Pt 2): p. 1. 
18. Chen, Y., Rennie, D.C., and Dosman, J.A.Influence of environmental tobacco smoke on 
asthma in nonallergic and allergic children. Epidemiology, 1996: p. 536-539. 
19. Medical Section of the American Lung Association, American Thoracic Society 
Standardization of Spirometry, 1994 Update, 2012. 
20. Mead, J.Problems in interpreting common tests of pulmonary mechanical function. The 
lung in the transition between health and disease (Macklem PT, Permutt S, eds). New York: 
Marcel Dekker, 1979: p. 43-51. 
21. Committee, H.I.S.O.Outdoor air pollution and health in the developing countries of Asia: 
a comprehensive review. Special report 18. Health Effects Institute, Boston, MA, 2010. 
22. Duquenne, P., Marchand, G., and Duchaine, C.Measurement of endotoxins in bioaerosols 
at workplace: a critical review of literature and a standardization issue. Annals of 
occupational hygiene, 2013. 57(2): p. 137-172. 
23. Thorn, J. and Rylander, R.Inflammatory response after inhalation of bacterial endotoxin 
assessed by the induced sputum technique. Thorax, 1998. 53(12): p. 1047-1052. 
   
104 
 
24. Wang, X., Pan, L., Zhang, H., Sun, B., Dai, H., and Christiani, D.A longitudinal 
observation of early pulmonary responses to cotton dust. Occupational and environmental 
medicine, 2003. 60(2): p. 115-121. 
25. Van Der Zee, S., Hoek, G., Boezen, M., Schouten, J., Van Wijnen, J., and Brunekreef, 
B.Acute effects of air pollution on respiratory health of 50-70 yr old adults. European 
Respiratory Journal, 2000. 15(4): p. 700-709. 
26. Lawson, J.A., Dosman, J.A., Rennie, D.C., Beach, J., Newman, S.C., and Senthilselvan, 
A.The association between endotoxin and lung function among children and adolescents 
living in a rural area. Canadian respiratory journal: journal of the Canadian Thoracic 
Society, 2011. 18(6): p. e89. 
27. Rabinovitch, N., Liu, A.H., Zhang, L., Rodes, C.E., Foarde, K., Dutton, S.J., Murphy, J.R., 
and Gelfand, E.W.Importance of the personal endotoxin cloud in school-age children with 
asthma. Journal of Allergy and Clinical Immunology, 2005. 116(5): p. 1053-1057. 
28. Tager, I.B., Lurmann, F.W., Haight, T., Alcorn, S., Penfold, B., and Hammond, 
S.K.Research| Children’s Health. Environmental health perspectives, 2010. 118(10): p. 
1491. 
29. Valavanidis, A., Fiotakis, K., and Vlachogianni, T.Airborne particulate matter and human 
health: toxicological assessment and importance of size and composition of particles for 
oxidative damage and carcinogenic mechanisms. Journal of Environmental Science and 
Health, Part C, 2008. 26(4): p. 339-362. 
30. Sebastian, A., Pehrson, C., and Larsson, L.Elevated concentrations of endotoxin in indoor 
air due to cigarette smoking. Journal of environmental monitoring, 2006. 8(5): p. 519-522. 
31. Rylander, R.Endotoxin in the environment--exposure and effects. J Endotoxin Res, 2002. 
8(4): p. 241-52. 
32. Carty, C.L., Gehring, U., Cyrys, J., Bischof, W., and Heinrich, J.Seasonal variability of 
endotoxin in ambient fine particulate matter. J Environ Monit, 2003. 5(6): p. 953-8. 
33. Lawson, J.A., Dosman, J.A., Rennie, D.C., Beach, J., Newman, S.C., and Senthilselvan, 
A.The association between endotoxin and lung function among children and adolescents 
living in a rural area. Canadian Respiratory Journal, 2011. 18(6): p. e89-e94. 
34. Braun-Fahrländer, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., Maisch, S., 
Carr, D., Gerlach, F., and Bufe, A.Environmental exposure to endotoxin and its relation to 
   
105 
 
asthma in school-age children. New England Journal of Medicine, 2002. 347(12): p. 869-
877. 
35. Lacey, J. and Dutkiewicz, J.Bioaerosols and occupational lung disease. Journal of aerosol 
science, 1994. 25(8): p. 1371-1404. 
36. Castellan, R.M., Olenchock, S.A., Kinsley, K.B., and Hankinson, J.L.Inhaled endotoxin 
and decreased spirometric values. New England Journal of Medicine, 1987. 317(10): p. 
605-610. 
37. Park, J.-H., Spiegelman, D.L., Burge, H.A., Gold, D.R., Chew, G.L., and Milton, 
D.K.Longitudinal study of dust and airborne endotoxin in the home. Environmental health 
perspectives, 2000. 108(11): p. 1023. 
38. Zock, J.P., Hollander, A., Heederik, D., and Douwes, J.Acute lung function changes and 
low endotoxin exposures in the potato processing industry. American journal of industrial 
medicine, 1998. 33(4): p. 384-391. 
39. Spaan, S., Doekes, G., Heederik, D., Thorne, P.S., and Wouters, I.M.Effect of extraction 
and assay media on analysis of airborne endotoxin. Applied and environmental 
microbiology, 2008. 74(12): p. 3804-3811. 
40. Bergstrand, A., Svanberg, C., Langton, M., and Nydén, M.Aggregation behavior and size 
of lipopolysaccharide from Escherichia coli O55: B5. Colloids and Surfaces B: 
Biointerfaces, 2006. 53(1): p. 9-14. 
41. Rietschel, E.T., Brade, H., Brade, L., Kaca, W., Kawahara, K., Lindner, B., Lüderitz, T., 
Tomita, T., Schade, U., and Seydel, U.Newer aspects of the chemical structure and 
biological activity of bacterial endotoxins. Progress in clinical and biological research, 
1984. 189: p. 31-51.
    
 
1
0
6
 
Table 5-1. Characteristics of the study population by phase. 
 Estevan Swift Current P-value 
Original sample size (#Final), n 
 Phase 1 
 Phase 2 
 Phase 3 
  
35 (31) 
45 (36) 
40 (38) 
 
36 (28) 
45 (37) 
42 (39) 
 
Sex % 
    Males 
         Phase 1 
         Phase 2 
         Phase 3 
 
 
32.2 
36.1 
36.8 
 
 
35.7 
35.1 
33.3 
 
 
           0.78 
           0.41 
           0.34 
Age, years, Mean (SD) 
         Phase 1 
         Phase 2 
         Phase 3 
 
           64.52 (9.67) 
  64.72 (10.76) 
 63.13 (10.34) 
 
  62.50 (10.93) 
63.59 (9.92) 
64.44 (9.82) 
 
           0.46   
           0.64 
           0.57      
Height, cm, Mean (SD) 
         Phase 1 
         Phase 2 
         Phase 3 
 
164.65 (8.77) 
166.11 (8.99) 
165.85 (8.18) 
 
 
166.16 (12.93) 
166.34 (11.43) 
165.35 (11.43) 
 
            0.60 
            0.93 
            0.83 
Current smoking, n (%) 
         Phase 1 
         Phase 2 
         Phase 3 
 
4 (12.9) 
9 (13.9) 
4 (10.5) 
 
1 (3.6) 
3 (8.1) 
                 3 (7.7)  
 
            0.15 
            0.46 
            0.29 
# The number of participants that completed the study. 
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                 Table 5-2. Summary of endotoxin geometric means by phase and community. 
 
 
 
 
 
 
 
 
 
 
 
Phase 1 (April-June 2013); Phase 2 (October-December 2013); Phase 3 (April-June 2014); Combined Phases (Phases 1-3 combined); min minimum; max maximum; GM 
geometric mean; GSD geometric standard deviation. 
 
Variable                                                   Estevan                                Swift Current 
                Endotoxin load 
       GM (GSD)        Min-Max          
   Endotoxin concentration 
GM (GSD)         Min-Max      
    Endotoxin load 
GM (GSD)         Min-Max      
Endotoxin concentration 
GM (GSD)         Min-Max      
Phase 1 
PM2.5 
PM10 
 
      0.02 (1.61)          0.01-0.04          
      0.02 (6.10)      0.0014-1.24      
 
0.04 (1.94)      0.01-0.08                
 0.01 (7.75)      0.0002-0.33      
 
0.04 (3.60)         0.01-0.52          
0.02 (2.86)         0.00-0.05       
 
0.07 (3.66)        0.01-1.16      
0.003 (3.34)      0.00-0.02       
 
Phase 2 
PM2.5 
PM10 
 
 
      0.03 (2.09)          0.01-0.05          
      0.01 (4.26)          0.001-0.03              
 
 
0.07 (2.53)      0.02-0.18              
0.004 (5.38)    0.0003-0.033    
 
 
0.10 (2.43)        0.04-0.61          
0.03 (2.99)        0.01-0.33        
 
 
0.13 (2.18)         0.07-0.77         
0.01 (4.79)         0.00-0.10       
 
Phase 3 
PM2.5 
PM10 
 
 
      0.01 (1.97)          0.003-0.025      
      0.01 (2.15)          0.00-0.01        
 
 
0.02 (1.58)      0.01-0.03 
 0.002 (2.69)    0.0005-0.006  
            
 
 
0.05 (1.51)        0.22-0.89        
0.02 (3.68)        0.005-0.45     
 
 
0.08 (0.58)        0.03-0.18          
 0.01 (3.84)        0.002-0.17     
Combined Phases 
PM2.5 
PM10 
 
      0.01 (2.15)          0.00-0.05          
      0.01 (4.44)          0.01-1.24        
 
0.03 (2.36)      0.01-0.18 
 0.003 (5.32)    0.00-0.33 
 
0.05 (2.68)       0.01-0.61            
0.02 (3.23)       0.00-0.45               
 
0.09 (2.57)         0.01-1.16       
0.01 (3.95)         0.00-0.17       
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Table 5-3. Forced Expiratory Volume in 1 second (FEV1) by community. 
 
 Estevan  Swift Current  
 Morning 
L (95% Cl) 
Evening 
L (95% Cl) 
Morning 
L (95% Cl) 
Evening 
L (95% Cl) 
Phase 1  
          Mean 
          Min 
          Max 
 
2.27 (2.07-2.47) 
2.14 (1.95-2.32) 
2.43 (2.05-2.81) 
 
2.22 (2.04-2.40) 
2.08 (1.90-2.26) 
2.38 (2.19-2.57) 
 
2.34 (2.14-2.53) 
2.18 (1.98-2.38) 
2.49 (2.30-2.68) 
 
2.30 (2.10-2.49) 
2.15 (1.96-2.35) 
2.45 (2.25-2.65) 
Phase 2  
          Mean 
          Min 
          Max 
 
2.42 (2.24-2.61) 
2.28 (2.10-2.45) 
2.73 (2.37-3.09) 
 
2.33 (2.16-2.50) 
2.22 (2.05-2.39) 
2.44 (2.26-2.62) 
 
2.50 (2.33-2.67) 
2.39 (2.21-2.57) 
2.61 (2.45-2.78) 
 
2.46 (2.29-2.63) 
2.34 (2.16-2.51) 
2.62 (2.44-2.79) 
Phase 3  
          Mean 
          Min 
          Max 
 
2.41 (2.23-2.59) 
2.29 (2.12-2.46) 
2.52 (2.18-2.86) 
 
2.35 (2.19-2.51) 
2.22 (2.06-2.39) 
2.49 (2.32-2.66) 
 
2.48 (2.31-2.65) 
2.37 (2.20-2.54) 
2.61 (2.44-2.77) 
 
2.43 (2.26-2.59) 
2.31 (2.14-2.48) 
2.56 (2.39-2.73) 
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Table 5-4. Association between endotoxin concentration (EU/m3) in PM2.5 and FEV1 (L) by 
community. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Phase 1      
Morning MeanFEV1  -0.005 0.005 0.34 -0.003 0.002 0.25 
               MinFEV1   -0.017 0.008 0.05 -0.003 0.003 0.25 
               MaxFEV1   0.009 0.013 0.51 -0.005 0.005 0.39 
       
Evening MeanFEV1  0.002 0.006 0.73 0.002 0.005 0.76 
              MinFEV1    0.008 0.008 0.28 0.012 0.015 0.43 
              MaxFEV1    0.006 0.018 0.75 0.01 0.009 0.33 
       
Phase 2       
Morning MeanFEV1    0.04 0.043 0.36 -0.001 0.007 0.89 
               MinFEV1   -0.001 0.008 0.86  0.002 0.008 0.78 
               MaxFEV1    0.28 0.300 0.35 -0.003 0.009 0.76 
       
Evening MeanFEV1  <0.001 0.005 1.00 -0.003 0.011 0.75 
              MinFEV1    -0.008 0.006 0.15  0.008 0.013 0.55 
              MaxFEV1     0.009 0.008 0.24 -0.029 0.037 0.43 
       
Phase 3       
Morning MeanFEV1  -0.009 0.007 0.20 -0.03 0.017 0.05 
               MinFEV1    0.001 0.012 0.96 -0.02 0.016 0.14 
               MaxFEV1  -0.007 0.016 0.67 -0.05 0.024 0.05 
       
Evening MeanFEV1  -0.022 0.013 0.08 -0.03 0.015 0.11 
              MinFEV1    -0.023 0.013 0.08 -0.01 0.016 0.49 
              MaxFEV1    -0.026 0.028 0.35 -0.03 0.030 0.25 
Adjusted for age, gender, height and smoking status. 
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Table 5-5. Association between endotoxin concentration (EU/m3) in PM10 and FEV1 (L) by 
community. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Phase 1      
Morning MeanFEV1   0.001 0.004 0.71 -0.013 0.009 0.15 
               MinFEV1   
               MaxFEV1  
-0.005 
 0.015 
0.006 
0.009 
0.41 
0.11 
<0.003 
-0.01 
0.004 
0.001 
0.39 
0.16 
 
Evening MeanFEV1  0.005 0.004 0.20 -0.018 0.012 0.14 
              MinFEV1    0.004 0.005 0.39 -0.013 0.011 0.23 
              MaxFEV1    0.019 0.014 0.17 -0.013 0.011 0.20 
       
Phase 2        
Morning MeanFEV1  -0.026 0.027 0.32  0.002 0.003 0.52 
               MinFEV1    0.006 0.006 0.36  0.006 0.004 0.18 
               MaxFEV1   0.205 0.184 0.27 -0.005 0.004 0.20 
       
Evening MeanFEV1   0.005 0.006 0.34 -0.008 0.009 0.34 
              MinFEV1     0.001 0.007 0.87  0.003 0.004 0.50 
              MaxFEV1    <0.001 0.010 0.95 -0.06 0.052 0.25 
       
Phase 3       
Morning MeanFEV1  0.012 0.007 0.11 -0.004 0.038 0.30 
               MinFEV1   0.011 0.006 0.06 -0.005 0.005 0.31 
               MaxFEV1  0.017 0.018 0.35 0.001 0.006 0.83 
       
Evening MeanFEV1  0.011 0.009 0.20 0.001 0.006 0.91 
              MinFEV1    0.003 0.008 0.66 <0.001 0.005 0.93 
              MaxFEV1    0.030 0.023 0.19 0.016 0.013 0.24 
Adjusted for age, gender, height and smoking status. 
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Table 5-6. Association between endotoxin concentration (EU/µg) in PM2.5 and FEV1 (L) by 
community. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Phase 1      
Morning MeanFEV1  0.006 0.015 0.61 -0.003 0.002 0.34 
               MinFEV1   0.002 0.019 0.90 <0.001 0.005 0.97 
               MaxFEV1  0.038 0.036 0.28 -0.008 0.006 0.20 
       
Evening MeanFEV1  0.017 0.013 0.18 -0.002 0.006 0.76 
              MinFEV1    0.003 0.017 0.85 0.007 0.012 0.58 
              MaxFEV1    0.052 0.043 0.24 0.005 0.011 0.63 
       
Phase 2       
Morning MeanFEV1    0.035 0.038 0.36 -0.002 0.008 0.76 
               MinFEV1     0.003 0.010 0.79  0.002 0.007 0.77 
               MaxFEV1    0.222 0.263 0.40 -0.006 0.010 0.52 
       
Evening MeanFEV1  0.004 0.006 1.00 -0.006 0.009 0.47 
              MinFEV1    -0.010 0.006 0.09  0.009 0.009 0.31 
              MaxFEV1     0.013 0.010 0.20 -0.035 0.029 0.23 
       
Phase 3       
Morning MeanFEV1  -0.016 0.019 0.38 -0.04 0.019 0.03 
               MinFEV1    0.009 0.009 0.32 -0.02 0.016 0.29 
               MaxFEV1  -0.040 0.038 0.29 -0.06 0.03 0.03 
       
Evening MeanFEV1  -0.017 0.023 0.46 -0.03 0.014 0.02 
              MinFEV1    -0.001 0.016 0.97 -0.01 0.015 0.49 
              MaxFEV1    -0.052 0.049 0.29 -0.07 0.037 0.05 
Adjusted for age, gender, height and smoking status. 
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Table 5-7. Association between endotoxin concentration (EU/µg) in PM10 and FEV1 (L) by 
community. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Phase 1      
Morning MeanFEV1  0.002 0.006 0.70 -0.017 0.011 0.14 
               MinFEV1   -0.006 0.009 0.50 -0.006 0.006 0.29 
               MaxFEV1   0.020 0.013 0.11 -0.013 0.008 0.14 
       
Evening MeanFEV1  0.006 0.005 0.22 -0.022 0.015 0.14 
              MinFEV1    0.004 0.007 0.51 -0.015 0.012 0.21 
              MaxFEV1    0.025 0.018 0.16 -0.015 0.013 0.25 
       
Phase 2       
Morning MeanFEV1    -0.035 0.034 0.31 -0.003 0.005 0.58 
               MinFEV1   0.005 0.010 0.58  0.006 0.006 0.31 
               MaxFEV1   -0.257 0.254 0.27 -0.003 0.006 0.64 
       
Evening MeanFEV1  0.006 0.009 0.47 -0.006 0.008 0.44 
              MinFEV1    0.003 0.010 0.76  0.005 0.007 0.44 
              MaxFEV1    -0.002 0.010 0.88 -0.049 0.037 0.18 
       
Phase 3       
Morning MeanFEV1  0.014 0.010 0.14 -0.002 0.004 0.65 
               MinFEV1   0.014 0.009 0.14 -0.003 0.004 0.55 
               MaxFEV1  0.015 0.022 0.49 0.004 0.006 0.47 
       
Evening MeanFEV1  0.013 0.011 0.24 0.003 0.005 0.63 
              MinFEV1    0.005 0.001 0.70 0.001 0.004 0.81 
              MaxFEV1    0.033 0.025 0.20 0.017 0.014 0.22 
Adjusted for age, gender, height and smoking status. 
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CHAPTER 6    DISCUSSION 
 
6.1 Summary and bridge of the two manuscripts 
This project used data from a panel study that was designed to assess the impact of airborne 
environmental contaminants on respiratory health in Saskatchewan, focusing on the communities 
of Estevan and Swift Current.  This thesis had two objectives: 1) to determine the levels of 
endotoxin and its distribution between the particulate sizes in two rural communities in 
Saskatchewan, Canada and 2) to examine the associations between endotoxin in PM (2.5 & 10) 
and FEV1 from lung function tests.  Results from the first objective focused on levels of endotoxin 
while the second objective extended the investigation to look at the associations between those 
endotoxin levels and lung function. 
Previous studies have shown that endotoxin has the potential to increase the toxicity of 
particulate matter and upon inhalation impact the FEV1 [1-3].  Earlier studies have shown that 
endotoxin levels in an agricultural environment or agricultural facility are higher compared to other 
environments [4-6] but this has not been studied in rural Saskatchewan communities.  A previous 
study revealed that asthma prevalence was higher in Estevan compared to Swift Current among 
children [7].  Estevan is a small urban community with a composition of few industries (such as 
oil and gas exploration, mining and power generation industry), that have the capacity to generate 
particulate matter, and endotoxin has become an important component of particulate matter 
associated with respiratory health [3]. 
The first objective was to identify the amount of endotoxin present in these regions. In 
Estevan, the highest geometric mean of endotoxin found was 0.03 EU/µg and 0.07 EU/m3. In Swift 
Current, the highest value was 0.10 EU/µg and 0.13 in EU/m3.  In general, our measurements 
showed that the mean endotoxin level found in Swift Current, primarily an agricultural 
environment, was significantly higher compared to Estevan, an industrial community with open 
coal mining and minor agricultural activities.  This confirms results from previous studies showing 
that agricultural environments experience higher levels of endotoxin as compared to other 
environments [4, 8].  In this study the highest levels of endotoxin were found in the fall (Phase 2).  
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These results are similar to a study from British Columbia that found the highest levels of 
endotoxin during fall with lowest levels in spring [9].  This might be due to seasonal agricultural 
activities.  The observed endotoxin levels found in Estevan might result from Sebastian et al.,’s 
[10] observation that heated particulate matter generated from industry has the capacity to 
inactivate the bioactive potency of endotoxin, therefore, resulting in low bioactive response to LAL 
assay. 
The first objective further identified the differences in particulate size fraction of endotoxin 
which might indicate lung deposition characteristics and useful to explain differences in respiratory 
outcomes observed in both communities.  However, only one outcome was studied in this thesis.  
In Estevan, there were no statistically significant differences between endotoxin in PM2.5 and 
endotoxin in PM10 (lowest p-value 0.15) as measured in endotoxin unit per microgram.  In Swift 
Current, statistically significant differences between PM2.5 and PM10 were found in Phases 2 and 
3 (measured in EU/µg).  Considering measurement of endotoxin in EU/m3, there were significant 
differences in all phases and both communities (p-values < 0.001). In comparing endotoxin PM2.5 
(EU/µg) between the two communities, there were significant differences, with higher levels in 
Swift Current than in Estevan (p-value < 0.001); a similar trend was found in endotoxin PM10 
(EU/µg) with the exception of Phase 1 (p>0.05).  Endotoxin PM2.5 and PM10 in EU/m
3 were similar 
with statistically significant difference found only in Phase 3 of the study (P<0.05).  This supports 
the hypothesis that there are differences in the particulate size fraction of endotoxin with higher 
levels in PM2.5 than PM10.  Most previous studies showed higher levels in PM10 than PM2.5 
(summary in table 4-5).  The reason for the observed distribution in this study is not clear.  
The second objective furthered the results by assessing possible association(s) between 
ambient endotoxin and FEV1 in the two communities.  In Estevan, no consistent association was 
found for endotoxin with either PM measured by EU/m3 or EU/µg.  By combining the phases, an 
association was found in the evening FEV1 for PM2.5, p=0.05 (EU/m
3 and EU/µg).  However, 
endotoxin (PM2.5) in Swift Current was found to be associated with morning and evening FEV1 in 
Phase 3, with both mean and maximum FEV1, being statistically significant.  In the combined 
phases, only morning FEV1 was associated with PM2.5 in both units of endotoxin.  Overall, 
however, there is no consistent pattern of association in this study.  One of the reasons for the lack 
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of association might be the low levels of endotoxin observed in the study described in the first 
manuscript.  Although the association has been established in some studies between workplace 
endotoxin and FEV1 (summary in Table 2-4) which might be due to higher exposure and proximity 
to the source than from the ambient air.  For instance, a study among the sewage workers by 
Cyprowski et al. found the concentration of endotoxin ranged from 0.68 to 214 EU/m3.  In an 
association with the changes in pulmonary function, they concluded that exposure to low 
endotoxin levels causes a significant decline in FEV1 [11].  The higher levels of endotoxin found 
in PM2.5 compared to PM10, reported in the study described in the first manuscript, might contribute 
to the few associations observed between endotoxin in PM2.5 and FEV1, while endotoxin in PM10 
showed a negligible association.  In general, endotoxins in this study, which can impact FEV1, 
were very low compared to the reported limits in other similar studies.  For instance, Donham et 
al. in an occupational exposure study, such as poultry farming, recommended an exposure limit of 
14 EU/m3 for total endotoxin while 7.15 EU/m3 for respirable endotoxin [12].  Additionally, 
Rylander also calculated the limit of exposure to be 33 ng/m3 [13].  This observation is not in line 
with our hypothesis that endotoxins in this two communities are associated with the FEV1 
measured among adult residents. 
6.2 Study validity 
6.2.1 Internal validity  
6.2.1.1 Selection bias 
In the first manuscript, selection bias is not a major problem.  The period of study was 
selected based on the three years’ historical pattern of air pollution in the province with maximum 
pollution observation in April-June and October-December.  Also, the site of sampling in each 
community was based on the Saskatchewan Air Monitoring directive.  In the second manuscript, 
the source population for this study was adult residents in the two communities.  The adults were 
restricted to age 50 and above, residing in the study locations and not living in a nursing home.  
This is to capture the age range that is more susceptible to develop acute respiratory illness and be 
    
116 
 
 
 
potentially more responsive to air pollutants.  It also includes adults that can walk outside their 
homes and were likely exposed to ambient endotoxin. 
Despite the use of volunteers from the call lists of Lung Association, the descriptive analysis 
did not show any significant difference between participants from each community. However, 
there is the possibility of underestimation of association if the adults that refused to participate had 
higher exposure or were more likely to exhibit lower FEV1 as compared to adults that participated.  
The percentage of adults that refused to participate from the source population was not known.  
Furthermore, selective attrition due to drop out may occur as a result of moving from one area to 
the other or becoming homebound due to sickness or just lack of interest [14]. The observed 
percentage of drop out from the study was quite similar in Estevan and Swift Current communities 
except in Phase 1 (Phase 1: 11% vs 22%, Phase 2: 16% vs 18%, Phase 3: 5% vs 7%).  Among the 
participants, the ‘healthy workers (adults) effect’ is unlikely to distort the association because of 
the age range and most are in retirement stage (above 60).  
6.2.1.2 Information bias 
Sampling equipment was co-located with provincial air monitoring equipment with the site 
selection based on the Saskatchewan Air Monitoring Directive, a strength for the environmental 
study results.  The environmental sampling site represents an efficient assessment of air quality 
for the general public in the area (i.e. Estevan and Swift Current) taking into account important 
variables in exposure including air dispersion, topographical effects, and local interferences.  This 
is the common measure for ambient exposure, although not predictive of personal exposure.  The 
assessment was objectively measured using identical equipment for each site and quantitative 
kinetic chromogenic limulus amoebocytes lysate method that has been widely used in other studies 
and to detect low levels of bioactive endotoxin.  The residents were blinded, in other words, not 
aware of the simultaneous environmental sample collection, which could have led to over 
estimation of respiratory outcomes.  The FEV1 outcome was also objectively measured using daily 
diary and the peak flow meter (FEV1 range from 0.15 to 9.99 and the accuracy is ±3.5% or 0.05 
L).  The use of daily diary reduced the error due to recall, as participants recorded the results 
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immediately after being measured.  The content of the diary was based on the past questionnaire 
used in the same province. 
6.2.1.3 Confounding factors 
The etiology of respiratory illnesses is complex, but in this thesis, a few previously studied 
confounders including age, height, gender, and smoking status were adjusted in the GEEs analysis.  
However, as in all epidemiological research, the overall study had practical limitations on the data 
collection used and the amount of data obtained from each participant.  This could result in residual 
confounders that might be misclassified, or not available for inclusion in the analysis such as 
migration, health status, home dampness, mould, indoor endotoxin levels could have influenced 
some of the associations.  For instance, based on characteristics of this study that involved time-
series, it could be difficult to draw associations due to challenges in determining actual pollutant 
concentrations to which people are exposed, possibly allowing the potential for misclassification 
of exposure. 
6.2.2 External validity 
External validity refers to how the findings from a study can be extended to other populations 
[15].  Generalization of these results should be done with caution, as this type of study design 
usually requires a lengthy time and is often expensive.  Therefore, only a small group of people 
are usually available [16].  This might make it difficult to apply the results to a larger population.  
For example, one potential threat to external validity could be that adults residing in urban 
communities or busy cities or moving to-and-from to other cities were not included in this study.  
Also, the study recruited adults from rural communities, thereby limiting the generalizability of 
the current study findings to urban residents. 
Time series design has shown that ambient air quality might vary over a short distance in an 
urban area, which may lead to underestimation of exposure and related health impacts.  Therefore, 
our results might not be generalizable to those populations, since our study is in a rural, small 
industrial area.  It is possible the participants are exposed to other pollutants which may complicate 
or further lower their FEV1.  In general, levels of endotoxin and the observed associations may be 
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generalized to other adults within Canada with similar industrial and agricultural activities. Since 
endotoxin is strongly associated with agricultural environments, generalization should be 
undertaken cautiously in other countries with different industrial settings. 
6.2.3 Other strengths and limitations 
The studies described in both manuscripts share some common strengths and limitations, a 
few of which were mentioned in Chapters 4 and 5.  A broad range of variables was collected in 
the original study.  Most variables used in this study were obtained objectively, that is, endotoxin, 
FEV1 and height, therefore reducing the chance for error due to measurement.  The investigation 
of outdoor endotoxin was a strength of this study.  As stated in Chapters 2 and 5, most previous 
studies evaluated indoor or workplace endotoxins.  Furthermore, the present study further 
examined endotoxin levels and made comparisons between particulate sizes.  Endotoxin research 
often features only one of the particulate sizes, or both but without statistical comparison.  The 
current study contributes to the rare research on the potential effects ambient endotoxin might have 
on adult lung function. 
As mentioned earlier, the objective assessment of endotoxin using the KQCL test as opposed 
to other methods such as kinetic turbidimetric LAL or recombinant Factor C is important in this 
study.  Apart from reducing measurement error, it also allows for comparison with other studies. 
However, it is important to consider some limitations in our laboratory tests. Interference of 
β-1, 3-glucan from fungus could activate Factor G in the reactions which might affect endotoxin 
levels [8, 17] and eventually distort the association.  Another factor that might influence the level 
of endotoxin is storage time, that is, the time between collection of dust samples and the time of 
laboratory analysis.  Laitinen found that endotoxin content dropped 10%, 30%, and 70% after 2, 
7, and 14 days of storage, respectively [17].  This could result in underestimations in the quantity 
of our endotoxin. 
Several epidemiological studies were targeted towards children respiratory health but this 
study focused on rural adult residents, which is an important strength.  Based on the study design, 
it will be difficult to establish a temporal relationship between the exposure and the outcome 
because the measurement of exposure and determination of outcome occurred simultaneously for 
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each participant.  A definite causal inference is therefore not possible in this study.  A dose-
response relationship between the independent variable and dependent variable can be important 
in the determination of illnesses.  Previous studies linked endotoxin and FEV1 but dose-response 
has not been established [18]. 
6.2.4 Future research recommendation 
Recommendations for future studies are necessary.  First, in our study, we found comparable 
but slightly lower endotoxin values as compared to other studies.  This study can be repeated with 
the intention of having a larger sample size.  Likewise, multiple sites for sample collection will 
also expand the knowledge of endotoxin pollution which might vary from one street to another 
based on the proximity to the source.  The use of personal sample collection could be suggested 
but might be difficult to achieve due to time factors. 
Another method that merits consideration in the future is Glickman’s method of spatial 
buffering [19], in which participants are assigned to a particular exposure group if their home 
address is within a pre-defined distance from industry or busy traffic road or agricultural facilities, 
referred to as “buffer zone”, while residents with addresses outside the zone can be considered 
unexposed.  This simple method would allow us to further compare the impact of endotoxin in 
different neighbourhoods and determine the effects of proximity.  Thirdly, to have a 
comprehensive knowledge of the endotoxin in Saskatchewan air, a chemical analytical method 
(Gas Chromatography-Mass Spectrometry, GC-MS) could be used to determine the total and 
bioactive endotoxin components of the dust.  This could contribute and generate a predictable or 
estimate level of toxin, and account for the presence of biologically active yet unexposed 
endotoxins which likely have endotoxic effects when inhaled. 
6.2.5 Conclusion of the thesis 
The justification of this thesis is to continue the investigation of lung health in the study 
regions.  Bacterial endotoxin is one of the biologically active constituents of organic particulate 
matter that is known to trigger inflammation along the respiratory tract.  Endotoxins are present in 
rural communities in Saskatchewan but in low amounts.  They were similar to levels found in a 
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few other studies.  In general, the associations between endotoxins and FEV1 were weak in this 
study, though few positive associations were found in Swift Current.  Findings from this thesis 
may add to the development of appropriate air quality guidelines in industrial communities. 
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APPENDICES 
Appendix A: Summary of the endotoxin analysis 
Dust Extraction 
 
1. Add 2 mg of 2 mm Zirconia beads into 2 mL bead beading tube. 
2. Place half of the filter in the 2 mL bead beading tube after taking the measurement of the  
            filter using sterile forceps. 
3. Add 1 mL of 0.05% Tween 20 in LPS free water. 
4. Place the tube in ice box. 
5. Bead beat each tube once for 3 mins on highest setting. At interval, place the tube in ice. 
6. Spin the tubes at Max (13,200 rpm) for 5 min. 
7. Transfer the supernatant into a new 1.5 mL tube. 
8. Spin the supernatant again at Max (13,200 rpm) for 10 min. 
9. Remove the supernatant and aliquot. Aliquot stores at -80%. 
 
Endotoxin Analysis 
 
 1.     Prepare standard solutions: 
 0.1 mL of 50 EU/mL + 0.9 mL = 5 EU/mL 
 0.1 mL of 5 EU/mL + 0.9 mL = 0.5 EU/mL 
 0.1 mL of 0.5 EU/mL + 0.9 mL = 0.05 EU/mL 
 0.1 mL of 0.05 EU/mL + 0.9 mL = 0.005 EU/mL 
             Vigorously vortex for at least 1 min before each proceeding. 
2.     Dispense 100 µL of the endotoxin standard, LAL reagent water blank, and samples (in 
triplicate). 
3.     Place the filled plate in the microplate reader and close the lid. 
4.     Pre-incubate the plate for 10 minutes @ 37oC. 
5.     Toward the end of preincubation, reconstitute each of the reagent vials with 2.6 mL reagent 
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water/vial. Mix gently but thoroughly. 
6.     Pool the reagents into a reagent reservoir and mix by gently rocking the reservoir from side 
to side. 
7.     Using an 8-channel multipipettor dispense 100 L of the Kinetic-QCL reagent into all wells 
of the microplate beginning with first column and proceeding in sequence to the last column used. 
Add reagents as quickly as possible. Avoid bubbles. 
8.     Immediately click on the OK button on the computer keyboard to initiate the test 
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Appendix B  Baseline questionnaire 
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Appendix C:  Daily diary 
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Appendix D:  Instructions for FEV 1 monitoring 
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Appendix E:  Template 96 – well plate 
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Appendix F:  Association between endotoxin and the lung function in a combined phase 
 
Table F1. Association between endotoxin concentration (EU/m3) in PM2.5 and FEV1 (L) by 
community in a combined phase. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Combined Phases       
Morning MeanFEV1   0.013 0.006 0.44 -0.007 0.004 0.05 
               MinFEV1   -0.007 0.005 0.15 -0.006 0.004 0.13 
               MaxFEV1   0.117 0.120 0.31 -0.011 0.006 0.07 
       
Evening MeanFEV1  -0.005 0.011 0.26 -0.004 0.007 0.36 
              MinFEV1    -0.006 0.010 0.23  0.007 0.014 0.52 
              MaxFEV1    -0.001 0.021 0.96 -0.007 0.009 0.54 
       
Adjusted for age, gender, height, phase and smoking status. 
 
Table F2. Association between endotoxin concentration (EU/m3) in PM10 and FEV1 (L) by 
community in a combined phase. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Combined Phases       
Morning MeanFEV1   0.002 0.006 0.74 -0.004 0.003 0.16 
               MinFEV1    0.003 0.004 0.47 <0.001 0.003 0.89 
               MaxFEV1  -0.013 0.027 0.62 -0.003 0.003 0.26 
       
Evening MeanFEV1  0.008 0.008 0.05 -0.007 0.005 0.13 
              MinFEV1    0.004 0.004 0.34 -0.002 0.003 0.57 
              MaxFEV1    0.021 0.011 0.05 -0.02 0.021 0.33 
       
Adjusted for age, gender, height, phase and smoking status. 
 
 
 
 
 
    
140 
 
 
 
Table F3. Association between endotoxin concentration (EU/µg) in PM2.5 and FEV1 (L) by 
community in a combined phase. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Combined Phases       
Morning MeanFEV1   0.007 0.015 0.65 -0.006 0.004 0.09 
               MinFEV1   -0.001 0.007 0.86 -0.002 0.004 0.64 
               MaxFEV1   0.063 0.088 0.47 -0.012 0.006 0.04 
       
Evening MeanFEV1  -0.001 0.011 0.92 -0.007 0.005 0.14 
              MinFEV1    -0.002 0.008 0.83  0.005 0.008 0.56 
              MaxFEV1    -0.004 0.024 0.87 -0.015 0.012 0.24 
       
          Adjusted for age, gender, height, phase and smoking status. 
 
 
Table F4. Association between endotoxin concentration (EU/µg) in PM10 and FEV1 (L) by 
community in a combined phase. 
 Estevan Swift Current 
 β (SE) P-value β (SE) P-value 
Combined Phases       
Morning MeanFEV1   0.003 0.007 0.65 -0.003 0.003 0.24 
               MinFEV1    0.003 0.006 0.57 -0.001 0.003 0.78 
               MaxFEV1  -0.012 0.029 0.69 -0.001 0.004 0.82 
       
Evening MeanFEV1  0.009 0.005 0.07 -0.005 0.004 0.28 
              MinFEV1    0.005 0.006 0.41 -0.001 0.004 0.79 
              MaxFEV1    0.026 0.013 0.05 -0.008 0.013 0.55 
       
           Adjusted for age, gender, height, phase and smoking status.
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Appendix G:  Interaction analysis results 
 
Table G1. Association between endotoxin concentration (EU/m3) in PM2.5 and FEV1 with 
interaction variable. 
 Estevan    Swift Current   
Combined phases β  SE P-value β SE P-value 
Morning MeanFEV1   0.009  0.03   0.77 -0.023 0.01 0.05 
               MinFEV1 -0.017 0.04 0.67 -0.03 0.02 0.06 
               MaxFEV1  0.161  0.16 0.31 -0.026 0.01 0.001 
       
Evening MeanFEV1  -0.04 0.03 0.18 -0.016 0.01 0.21 
              MinFEV1 -0.035 0.04 0.35 -0.004 0.02 0.80 
              MaxFEV1  -0.052 0.03 0.07 -0.014 0.02 0.48 
 
 
 
Table G2. Association between endotoxin concentration (EU/m3) in PM10 and FEV1 with 
interaction variable 
 Estevan    Swift Current   
Combined phases β SE P-value β SE P-value 
Morning MeanFEV1  0.004 0.02 0.80 0.004 0.01 0.77 
               MinFEV1  0.009 0.02 0.69 0.011 0.01 0.47 
               MaxFEV1  0.04 0.03 0.16 0.013 0.01 0.05 
       
Evening MeanFEV1  -0.016 0.01 0.26 -0.005 0.01 0.70 
               MinFEV1  -0.014 0.02 0.49 0.005 0.02 0.74 
               MaxFEV1  -0.014 0.02 0.35 -0.028 0.02 0.26 
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Table G3. Association between endotoxin load (EU/µg) in PM2.5 and FEV1 with interaction 
variable. 
 Estevan    Swift Current   
Combined phases Β SE P-value β SE P-value 
Morning MeanFEV1 0.019 0.03 0.56 <0.001  0.01 0.99 
               MinFEV1  -0.02 0.05 0.96 0.01 0.02 0.57 
               MaxFEV1 0.154 0.15 0.31 -0.013 0.01 0.11 
       
Evening MeanFEV1  -0.035 0.04 0.37 <0.001 0.02 0.49 
              MinFEV1 -0.026 0.05 0.56 0.02 0.02 0.49 
              MaxFEV1 -0.046 0.04 0.21 <0.001 0.02 0.99 
 
 
 
 
Table G4. Association between endotoxin load (EU/µg) in PM10 and FEV1 with interaction 
variable 
 Estevan    Swift Current   
Combined phases Β SE P-value β SE P-value 
Morning MeanFEV1  0.009 0.02 0.59 0.002 0.01 0.69 
               MinFEV1  0.019 0.03 0.52 0.013 0.01 0.17 
               MaxFEV1  0.051 0.04 0.15 0.006 0.01 0.39 
       
Evening MeanFEV1  -0.015 0.02 0.39 -0.005 0.01 0.60 
              MinFEV1  -0.013 0.02 0.57 0.004 0.01 0.68 
              MaxFEV1  -0.013 0.02 0.55 -0.011 0.01 0.37 
 
 
 
 
 
